Processing 00000000.tx.1: Branched-chain amino acids increase p70S6k phosphorylation in human skeletal muscle after resistance exercise Hkan K. 

Phrase: "Branched-chain amino acids"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "p70S6k phosphorylation in human skeletal muscle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "after resistance exercise Hkan K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: Karlsson,1,2,* Per-Anders Nilsson,1,3,* Johnny Nilsson,1 Alexander V. 

Phrase: "Karlsson,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "* Per-Anders Nilsson,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "* Johnny Nilsson,"

Phrase: "1 Alexander V."
Processing 00000000.tx.4: Chibalin,2 Juleen R. 

Phrase: "Chibalin,"

Phrase: "2 Juleen R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.5: Zierath,2 and Eva Blomstrand1,3 1Department of Health and Sport Sciences, University College of Physical Education and Sports, Stockholm S-114 86; 

Phrase: "Zierath,"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "Eva Blomstrand1,"

Phrase: "3 1Department of Health"

Phrase: "and"

Phrase: "Sport Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Sciences [Occupation or Discipline]

Phrase: "University College of Physical Education"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0870309:college education [Educational Activity]
   760   C0557806:College [Manufactured Object]

Phrase: "and"

Phrase: "Sports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "Stockholm"

Phrase: "S-"

Phrase: "114 86"

Phrase: ";"
Processing 00000000.tx.6: 2Section Integrative Physiology, Department of Surgical Sciences, Karolinska Institute, Stockholm, S-171 77; 

Phrase: "2Section Integrative Physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0031842:Physiology [Biomedical Occupation or Discipline]
   827   C0031843:physiology [Physiologic Function]
   755 E C0205463:Physiologic [Functional Concept]

Phrase: "Department of Surgical Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587503:Surgical department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Stockholm,"

Phrase: "S-"

Phrase: "171 77"

Phrase: ";"
Processing 00000000.tx.7: and 3Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, S-171 76, Sweden Submitted 25 September 2003 ; accepted in final form 24 February 2004 ABSTRACT The aim of the study was to investigate the effect of resistance exercise alone or in combination with oral intake of branched-chain amino acids (BCAA) on phosphorylation of the 70-kDa S6 protein kinase (p70S6k) and mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK1/2), and p38 MAPK in skeletal muscle. 

Phrase: "and"

Phrase: "3Department of Physiology"

Phrase: "and"

Phrase: "Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Stockholm,"

Phrase: "S-"

Phrase: "171 76,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "25 September 2003"

Phrase: ";"

Phrase: "accepted in final form 24 February 2004 ABSTRACT"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0000857:Abstract [Occupational Activity]
   744   C0205088:Final [Temporal Concept]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C0600678:Abstract [Intellectual Product]
   744   C1272684:Accepted [Qualitative Concept]
   744   C1522492:Form [Functional Concept]
   744   C1546485:Final [Idea or Concept]
   744   C1548435:Accepted [Idea or Concept]
   744   C1552863:Abstract [Idea or Concept]
   711 E C1548601:Accept [Idea or Concept]

Phrase: "The aim of the study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effect of resistance exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "with oral intake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512806:Intake [Functional Concept]

Phrase: "of branched-chain amino acids (BCAA)"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "on phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of the 70-kDa S6 protein kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "mitogen-activated protein kinase (MAPK),"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "extracellular signal-regulated kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "(ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "p38 MAPK in skeletal muscle."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   869   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   855 E C1120843:mitogen-activated protein kinase p38 [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   833   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0026249:Mitogen [Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1879547:Activated [Activity]
   711 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.8: Seven male subjects performed one session of quadriceps muscle resistance training (4 x 10 repetitions at 80% of one repetition maximum) on two occasions. 

Phrase: "Seven male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "performed one session of quadriceps muscle resistance training"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1883016:Session [Event]
   744   C1883017:Session [Conceptual Entity]

Phrase: "(4 x 10 repetitions at 80% of one repetition maximum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205341:repetitions [Functional Concept]

Phrase: ")"

Phrase: "on two occasions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C0521114:Occasional [Temporal Concept]
Processing 00000000.tx.9: In a randomized order, double-blind, crossover test, subjects ingested a solution of BCAA or placebo during and after exercise. 

Phrase: "In a randomized order,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "double-blind,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013072:DOUBLE BLIND [Research Activity]
   861   C0150108:Blind [Research Activity]
   861   C0205173:Double [Functional Concept]
   861   C0456909:Blind [Disease or Syndrome]
   861   C0525065:blind [Patient or Disabled Group]
   861   C1705764:Double [Activity]
   861   C1705765:Double [Qualitative Concept]

Phrase: "crossover test,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0431012:Crossover test [Laboratory Procedure]
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "ingested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232478:Ingested [Biologic Function]

Phrase: "a solution of BCAA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C0308312:AMINO ACID SOLUTION [Clinical Drug]
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]

Phrase: "or"

Phrase: "placebo during"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0032042:placebo [Therapeutic or Preventive Procedure]
   833   C1696465:placebo [Biomedical or Dental Material]
   833   C1706408:PLACEBO [Research Activity]

Phrase: "and after exercise."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.10: Ingestion of BCAA increased plasma concentrations of isoleucine, leucine, and valine during exercise and throughout recovery after exercise (2 h postexercise), whereas no change was noted after the placebo trial. 

Phrase: "Ingestion of BCAA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0237965:ACID INGESTION [Injury or Poisoning]
   753   C0232478:Ingestion [Biologic Function]
   716   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "plasma concentrations of isoleucine,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0683150:concentrations plasma [Quantitative Concept]
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "valine during exercise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and throughout recovery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0237820:Recovery [Activity]
   790   C1515981:And [Idea or Concept]
   790   C1555688:recovery [Idea or Concept]
   790   C2004454:Recovery [Organism Function]

Phrase: "after exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "(2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "postexercise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979962:post exercise [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "no change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "noted after the placebo trial."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0008976:Trial [Research Activity]
   760   C0032042:placebo [Therapeutic or Preventive Procedure]
   760   C1696465:placebo [Biomedical or Dental Material]
   760   C1706408:PLACEBO [Research Activity]
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.11: Resistance exercise led to a robust increase in p70S6k phosphorylation at Ser424 and/or Thr421, which persisted 1 and 2 h after exercise. 

Phrase: "Resistance exercise"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "led to a robust increase"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0442805:Increase [Functional Concept]
   760   C1708698:LED [Manufactured Object]
   760   C2986815:Robust [Qualitative Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in p70S6k phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Ser424"

Phrase: "and/or"

Phrase: "Thr421,"

Phrase: "which"

Phrase: "persisted"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2 h after exercise."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0011744:2 H [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.12: BCAA ingestion further enhanced p70S6k phosphorylation 3.5-fold during recovery. 

Phrase: "BCAA ingestion further enhanced p70S6k phosphorylation 3.5-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   787   C0332462:Fold [Spatial Concept]
   787   C1880834:FOLD [Phenomenon or Process]

Phrase: "during recovery."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]
Processing 00000000.tx.13: p70S6k phosphorylation at Thr389 was unaltered directly after resistance exercise. 

Phrase: "p70S6k phosphorylation at Thr389"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "unaltered directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1709843:Unaltered [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "after"

Phrase: "resistance exercise."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.14: However, during recovery, Thr389 phosphorylation was profoundly increased, but only during the BCAA trial. 

Phrase: "However,"

Phrase: "during recovery,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "Thr389 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "profoundly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "but"

Phrase: "only during the BCAA trial."
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   833   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0008976:Trial [Research Activity]
   744   C0205171:Only [Quantitative Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C1253959:branched [Body Part, Organ, or Organ Component]
   744   C1524075:Chain [Idea or Concept]
   744   C1720467:Only [Intellectual Product]
   744   C2700384:Branched [Spatial Concept]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C1881507:Branch [Chemical Viewed Structurally]
   711 E C2700383:Branch [Plant]
   711 E C2826234:BRANCH [Intellectual Product]
Processing 00000000.tx.15: Furthermore, phosphorylation of the ribosomal protein S6 was also increased in the recovery period only during the BCAA trial. 

Phrase: "Furthermore,"

Phrase: "phosphorylation of the ribosomal protein S6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "also"

Phrase: "increased in the recovery period only"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C2983655:Recovery Period [Temporal Concept]
   753   C0205171:Only [Quantitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0237820:Recovery [Activity]
   753   C0439531:/period [Temporal Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1555688:recovery [Idea or Concept]
   753   C1720467:Only [Intellectual Product]
   753   C1948053:Period [Temporal Concept]
   753   C2004454:Recovery [Organism Function]

Phrase: "during the BCAA trial."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0008976:Trial [Research Activity]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.16: Exercise led to a marked increase in ERK1/2 and p38 MAPK phosphorylation, which was completely suppressed upon recovery and unaltered by BCAA. 

Phrase: "Exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "led to a marked increase"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0442805:Increase [Functional Concept]
   760   C0522501:Marked [Qualitative Concept]
   760   C1706089:Marked [Qualitative Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p38 MAPK phosphorylation,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   839   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "suppressed upon recovery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0237820:Recovery [Activity]
   790   C1260953:Suppressed [Functional Concept]
   790   C1555688:recovery [Idea or Concept]
   790   C2004454:Recovery [Organism Function]

Phrase: "and"

Phrase: "unaltered by BCAA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1709843:Unaltered [Qualitative Concept]
   716   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.17: In conclusion, BCAA, ingested during and after resistance exercise, mediate signal transduction through p70S6k in skeletal muscle. exercise training; 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "BCAA,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "ingested during"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0232478:Ingested [Biologic Function]

Phrase: "and after resistance exercise,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1515981:And [Idea or Concept]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "signal transduction through p70S6k"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0037083:Signal Transduction [Cell Function]
   770   C1160185:transduction [Organism Function]
   770   C1710082:Signal [Phenomenon or Process]

Phrase: "in skeletal muscle. exercise training"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   812   C0015259:Exercise [Daily or Recreational Activity]
   812   C0040607:Training [Educational Activity]
   812   C0220931:Training [Educational Activity]
   812   C1522704:Exercise [Therapeutic or Preventive Procedure]
   812   C2673163:training [Qualitative Concept]
   779 E C0336809:Train [Manufactured Object]
   779 E C1552514:Train [Manufactured Object]
   741 E C0009647:Conditioned [Mental Process]
   741 E C0012634:condition [Disease or Syndrome]
   741 E C0348080:Condition [Qualitative Concept]
   741 E C1705253:Condition [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.18: mitogen-activated protein kinase; 

Phrase: "mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.19: protein synthesis; 

Phrase: "protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: ";"
Processing 00000000.tx.20: signal transduction RESISTANCE EXERCISE leads to changes in protein turnover in skeletal muscle that occur up to 48 h into the recovery period (22). 

Phrase: "signal transduction RESISTANCE EXERCISE"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   812   C0015259:Exercise [Daily or Recreational Activity]
   812   C0237834:Resistance [Mental Process]
   812   C1514892:Resistance [Physiologic Function]
   812   C1522704:Exercise [Therapeutic or Preventive Procedure]
   741 E C0332325:Resistant [Functional Concept]
   741 E C1550464:resistent [Idea or Concept]
   741 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "leads to changes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in protein turnover"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597297:Protein Turnover [Molecular Function]
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "that"

Phrase: "occur up to 48 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "into the recovery period"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2983655:Recovery Period [Temporal Concept]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.21: Regular resistance exercise training will induce an increase in protein synthesis and muscle mass. 

Phrase: "Regular resistance exercise training"
Meta Candidates (Total=19; Excluded=9; Pruned=0; Remaining=10)
   875   C0582191:Regular exercise [Daily or Recreational Activity]
   875   C0814409:resistance training [Health Care Activity]
   875   C0872279:Resistance Training [Therapeutic or Preventive Procedure]
   812   C0015259:Exercise [Daily or Recreational Activity]
   812   C0040607:Training [Educational Activity]
   812   C0220931:Training [Educational Activity]
   812   C0237834:Resistance [Mental Process]
   812   C1514892:Resistance [Physiologic Function]
   812   C1522704:Exercise [Therapeutic or Preventive Procedure]
   812   C2673163:training [Qualitative Concept]
   779 E C0336809:Train [Manufactured Object]
   779 E C1552514:Train [Manufactured Object]
   741 E C0009647:Conditioned [Mental Process]
   741 E C0012634:condition [Disease or Syndrome]
   741 E C0332325:Resistant [Functional Concept]
   741 E C0348080:Condition [Qualitative Concept]
   741 E C1550464:resistent [Idea or Concept]
   741 E C1705253:Condition [Conceptual Entity]
   741 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "will"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an increase in protein synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "muscle mass."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0240417:MUSCLE MASS [Finding]
   861   C0026845:Muscle [Tissue]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.22: The anabolic benefits of resistance exercise training are likely to be mediated through changes in signal transduction. 

Phrase: "The anabolic benefits of resistance exercise training"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0814225:Benefits [Quantitative Concept]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "mediated through changes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in signal transduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.23: The signaling networks controlling protein synthesis through translational initiation involve phosphorylation of the mammalian target of rapamycin and sequential activation of the 70-kDa S6 protein kinase (p70S6k) and the eukaryotic initiation factor 4E-binding protein 1 (13, 14, 20). 

Phrase: "The signaling networks"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1882071:networks [Conceptual Entity]
   827 E C1513822:Network [Professional or Occupational Group]
   827 E C1705739:Network [Manufactured Object]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "protein synthesis through translational initiation"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   844   C1157563:protein synthesis initiation [Genetic Function]
   844   C1448475:Translational Initiation, Protein [Genetic Function]
   806   C0597295:Protein Synthesis [Molecular Function]
           Protein Translation
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "involve"

Phrase: "phosphorylation of the mammalian target of rapamycin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "sequential activation of the 70-kDa S6 protein kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   784   C1819041:protein kinase activation [Cell Function]
   762   C0599177:protein activation [Genetic Function]
   742   C1879547:Activation [Activity]

Phrase: "(p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "the eukaryotic initiation factor 4E-binding protein 1"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   913   C1149297:eukaryotic initiation factor 4E binding [Genetic Function]
   911   C0013728:Eukaryotic Initiation Factor-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C0058988:Eukaryotic Initiation Factor-4E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0030943:Initiation Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0243122:binding [Functional Concept]
   795   C0450378:4e [Intellectual Product]
   795   C0589507:Initiation [Mental Process]
   795   C1145667:Binding [Activity]
   795   C1158830:Initiation [Genetic Function]
   795   C1167622:Binding [Molecular Function]
   795   C1521761:Factor [Functional Concept]
   795   C1704686:Initiation [Functional Concept]
   795   C2827422:Factor [Conceptual Entity]

Phrase: "(13,"

Phrase: "14,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.24: However, the specific cascades linking growth stimuli to the activation of protein synthesis in human skeletal muscle are not fully resolved. 

Phrase: "However,"

Phrase: "the specific cascades"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707310:Cascade [Manufactured Object]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "growth stimuli to the activation of protein synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0234402:Stimuli [Phenomenon or Process]

Phrase: "in human skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "are"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "resolved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.25: Increased amino acid availability and exercise both directly increase protein synthesis in skeletal muscle. 

Phrase: "Increased amino acid availability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0470187:Availability [Functional Concept]
   756   C1291157:Increased amino acid [Finding]

Phrase: "and"

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "both directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "protein synthesis in skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0597295:Protein Synthesis [Molecular Function]
   797   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]
Processing 00000000.tx.26: Branched-chain amino acids (BCAA; leucine, isoleucine, and valine), and in particular leucine, have anabolic effects on protein metabolism by increasing the rate of protein synthesis and decreasing the rate of protein degradation in resting human skeletal muscle (17, 19). 

Phrase: "Branched-chain amino acids"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "(BCAA"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "; leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "isoleucine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "and"

Phrase: "valine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and in particular leucine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1515981:And [Idea or Concept]

Phrase: "have"

Phrase: "anabolic effects on protein metabolism"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C3179309:Anabolic Effects [Physiologic Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "by increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the rate of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the rate of protein degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "in resting human skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0242692:Muscle, Skeletal [Tissue]
   861   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   812   C0026845:Muscle [Tissue]
   812   C0037253:skeletal [Body System]
   812   C0521324:Skeletal [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "(17,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.27: During recovery from exercise, BCAA have an anabolic effect in human skeletal muscle (4). 

Phrase: "During recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "from exercise,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "BCAA"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "have"

Phrase: "an anabolic effect in human skeletal muscle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C3179309:Anabolic Effect [Physiologic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.28: Furthermore, administration of BCAA increases the phosphorylation of proteins involved in the regulation of protein synthesis, including p70S6k, in human skeletal muscle (16). 

Phrase: "Furthermore,"

Phrase: "administration of BCAA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]
   716   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the phosphorylation of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   770   C0031715:Phosphorylation [Molecular Function]

Phrase: "involved in the regulation of protein synthesis,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   853   C1157519:regulation of protein synthesis [Cell Function]
   804   C1157723:regulation of synthesis [Molecular Function]
   778   C0597295:Protein Synthesis [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0220781:synthesis [Biologic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1883254:Synthesis [Activity]
   738 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "p70S6k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "in human skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.29: Exercise-induced p70S6k activity correlates with increased skeletal muscle mass after 6 wk of resistance training (1a) and with elevated rates of protein synthesis in rat skeletal muscle at 12 and 24 h of recovery (12). 

Phrase: "Exercise-induced p70S6k activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0695406:exercise activity [Therapeutic or Preventive Procedure]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "correlates with increased skeletal muscle mass"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0240417:MUSCLE MASS [Finding]
   790   C0242692:Muscle, Skeletal [Tissue]
   790   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   753   C0026845:Muscle [Tissue]
   753   C0037253:skeletal [Body System]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0521324:Skeletal [Spatial Concept]
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]

Phrase: "after 6 wk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "of resistance training"
Meta Candidates (Total=16; Excluded=9; Pruned=0; Remaining=7)
  1000   C0814409:resistance training [Health Care Activity]
  1000   C0872279:Resistance Training [Therapeutic or Preventive Procedure]
   861   C0040607:Training [Educational Activity]
   861   C0220931:Training [Educational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C2673163:training [Qualitative Concept]
   827 E C0336809:Train [Manufactured Object]
   827 E C1552514:Train [Manufactured Object]
   789 E C0009647:Conditioned [Mental Process]
   789 E C0012634:condition [Disease or Syndrome]
   789 E C0332325:Resistant [Functional Concept]
   789 E C0348080:Condition [Qualitative Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C1705253:Condition [Conceptual Entity]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "(1a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "and with elevated rates of protein synthesis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0597295:Protein Synthesis [Molecular Function]
   774   C0748024:elevated protein [Finding]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205250:Elevated [Qualitative Concept]
   748   C0220781:synthesis [Biologic Function]
   748   C1515981:And [Idea or Concept]
   748   C1883254:Synthesis [Activity]
   748   C3163633:Elevated [Qualitative Concept]
   738 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "in rat skeletal muscle"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "at 12"

Phrase: "and"

Phrase: "24 h of recovery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.30: Thus changes in p70S6k phosphorylation in skeletal muscle after exercise can reflect activation of putative signaling pathways that may account for increases in protein synthesis during the early recovery phase after exercise. 

Phrase: "Thus"

Phrase: "changes in p70S6k phosphorylation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1705241:Change [Quantitative Concept]
   770   C2827383:p70S6K [Enzyme]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "after exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "activation of putative signaling pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "that"

Phrase: "may"

Phrase: "account for increases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442805:increases [Functional Concept]
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]

Phrase: "in protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "during the early recovery phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205390:Phase [Temporal Concept]

Phrase: "after exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.31: However, the effects of exercise and amino acid supplementation on p70S6k phosphorylation directly after exercise and in the early recovery phase are unknown. 

Phrase: "However,"

Phrase: "the effects of exercise"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "amino acid supplementation on p70S6k phosphorylation directly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0556082:Amino acid supplementation [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   814   C1261361:Amino acid supplementation [Therapeutic or Preventive Procedure]
   748   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "after"

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "and in the early recovery phase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205390:Phase [Temporal Concept]
   753   C0237820:Recovery [Activity]
   753   C1279919:Early [Temporal Concept]
   753   C1515981:And [Idea or Concept]
   753   C1555688:recovery [Idea or Concept]
   753   C2004454:Recovery [Organism Function]

Phrase: "are"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.32: Muscle hypertrophy through increased protein synthesis may require activation of the mitogen-activated protein kinase (MAPK)-signaling cascades. 

Phrase: "Muscle hypertrophy through increased protein synthesis"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0236033:Muscle hypertrophy [Organ or Tissue Function]
   783   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754 E C1850647:Muscular hypertrophy [Finding]
   753   C0020564:Hypertrophy [Pathologic Function]
   753   C0026845:Muscle [Tissue]

Phrase: "may"

Phrase: "require"

Phrase: "activation of the mitogen-activated protein kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1819041:protein kinase activation [Cell Function]
   774   C0599177:protein activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "(MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ")-"

Phrase: "signaling cascades."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C2611812:signaling cascade [Cell Function]
   827   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.33: Increased MAPK signaling in response to endurance exercise regulates the activity of various transcription factors in skeletal muscle (26, 29). 

Phrase: "Increased MAPK signaling in response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]

Phrase: "to endurance exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0419120:endurance exercise [Therapeutic or Preventive Procedure]
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "regulates"

Phrase: "the activity of various transcription factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C1148759:transcription factor activity [Genetic Function]
   804   C3537021:Transcription Factor Activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "(26,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.34: Resistance exercise has recently been reported to increase phosphorylation of extracellular signal-regulated kinase (ERK)1/2 MAPK, but not p38 MAPK, in skeletal muscle from young male subjects (27). 

Phrase: "Resistance exercise"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of extracellular signal-regulated kinase (ERK)1/2 MAPK,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   884   C1456385:PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 2 [Gene or Genome]
   880   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C1334474:PROTEIN KINASE, MITOGEN-ACTIVATED, KINASE 1 [Gene or Genome]
   846   C0033640:kinase protein [Amino Acid, Peptide, or Protein,Enzyme]
           PROTEIN KINASE
   840   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   821   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   790   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0026249:Mitogen [Pharmacologic Substance]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "but"

Phrase: "not p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   947   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   926 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   901   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0026249:Mitogen [Pharmacologic Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1879547:Activated [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "from young male subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.35: However, information regarding the effects of BCAA on MAPK signaling during and after exercise is lacking. 

Phrase: "However,"

Phrase: "information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "regarding"

Phrase: "the effects of BCAA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on MAPK signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "during"

Phrase: "and after exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "lacking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]
Processing 00000000.tx.36: The purpose of the present study was to investigate the effect of resistance exercise alone or in combination with ingestion of BCAA on phosphorylation of p70S6k, the ribosomal protein S6, ERK1/2 MAPK, and p38 MAPK. 

Phrase: "The purpose of the present study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   820   C0681832:purpose of study [Research Activity]
   753   C1285529:Purpose [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effect of resistance exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "with ingestion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232478:Ingestion [Biologic Function]

Phrase: "of BCAA"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "on phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of p70S6k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "the ribosomal protein S6,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0073336:Ribosomal Protein S6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419741:RIBOSOMAL PROTEIN S6 [Gene or Genome]
           S6
   901   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1622856:ribosomal protein [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0035553:Ribosomal [Cell Component]
   827   C1419024:S6 [Gene or Genome]
   827   C1861424:S6 [Gene or Genome]
   827   C2348600:S6+ [Element, Ion, or Isotope]
   755 E C2984240:Ribosome [Functional Concept]

Phrase: "ERK1/2 MAPK,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   895   C0082529:ERK1 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0026249:Mitogen [Pharmacologic Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1879547:Activated [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "p38 MAPK."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.37: We hypothesized that BCAA would potentiate the effects of resistance exercise on signal transduction. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that BCAA"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "would"

Phrase: "potentiate"

Phrase: "the effects of resistance exercise"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on signal transduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.38: To test this hypothesis, healthy subjects ingested a solution of BCAA or placebo during and after resistance exercise. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "healthy subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1708335:HEALTHY SUBJECTS [Population Group]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "ingested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232478:Ingested [Biologic Function]

Phrase: "a solution of BCAA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C0308312:AMINO ACID SOLUTION [Clinical Drug]
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]

Phrase: "or"

Phrase: "placebo during"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0032042:placebo [Therapeutic or Preventive Procedure]
   833   C1696465:placebo [Biomedical or Dental Material]
   833   C1706408:PLACEBO [Research Activity]

Phrase: "and after resistance exercise."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1515981:And [Idea or Concept]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.39: Skeletal muscle biopsies were obtained, and phosphorylation of p70S6k, S6, ERK1/2 MAPK, and p38 MAPK was determined by immunoblot analysis by use of phosphospecific antibodies. 

Phrase: "Skeletal muscle biopsies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C0185283:Muscle biopsy [Diagnostic Procedure]
   827   C0005558:biopsies [Diagnostic Procedure]
   793 E C0220797:biopsy [Functional Concept]
   734   C0242692:Muscle, Skeletal [Tissue]
   734   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "and"

Phrase: "phosphorylation of p70S6k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "S6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1419024:S6 [Gene or Genome]
  1000   C1419741:S6 [Gene or Genome]
  1000   C1861424:S6 [Gene or Genome]
  1000   C2348600:S6+ [Element, Ion, or Isotope]

Phrase: "ERK1/2 MAPK,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   895   C0082529:ERK1 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0026249:Mitogen [Pharmacologic Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1879547:Activated [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "p38 MAPK"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "was"

Phrase: "determined by immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "by use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of phosphospecific antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.40: MATERIALS AND METHODS Subjects. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "Subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]
Processing 00000000.tx.41: Seven healthy men of age 25  1 yr, height 178  2 cm, weight 74.4  3.5 kg, and maximal oxygen uptake 3.78  0.20 l/min participated in the study. 

Phrase: "Seven healthy men of age 25  1 yr,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   767   C0025267:MEN 1 [Neoplastic Process]
   744   C0025266:Men [Population Group]
   731   C1456606:Men's Health [Group Attribute]
   711 E C0024554:MAN [Finding]
   711 E C0086418:Man [Human]

Phrase: "height 178  2 cm,"

Phrase: "weight 74.4  3.5 kg,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0022718:KG [Geographic Area]
   799   C0439209:kg [Quantitative Concept]

Phrase: "and"

Phrase: "maximal oxygen uptake 3.78  0.20 l/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0702093:/min [Temporal Concept]

Phrase: "participated in the study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.42: The subjects reported performing endurance or resistance exercise training 12 times weekly. 

Phrase: "The subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "performing endurance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0518031:Endurance [Finding]
   861   C2598169:Endurance [Clinical Attribute]

Phrase: "or"

Phrase: "resistance exercise training 12 times weekly."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   841   C0439587:Exercise time [Temporal Concept]
   799   C0040223:times [Temporal Concept]
   799   C1632851:Times [Quantitative Concept]
   766 E C3541383:Time [Temporal Concept]
   727 E C0442043:Temporal [Spatial Concept]
   727 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.43: The Ethics Committee at the Karolinska Institute approved the study protocol. 

Phrase: "The Ethics Committee at the Karolinska Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0085546:Ethics Committee [Professional or Occupational Group]
   748   C2699414:Committee [Group]

Phrase: "approved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205540:Approved [Qualitative Concept]

Phrase: "the study protocol."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1507394:Study Protocol [Intellectual Product]
           Protocol
  1000   C2348563:Study Protocol [Intellectual Product]
           Protocol
   861   C0442711:Protocol [Intellectual Product]
   861   C0557651:Study [Manufactured Object]
   861   C1522729:Protocol [Intellectual Product]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.44: Subjects were fully informed of the nature and the possible risks associated with the study before they volunteered to participate. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "fully"

Phrase: "informed of the nature"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0349590:Nature [Idea or Concept]
   770   C1262865:Nature [Functional Concept]
   770   C1522154:Informed [Qualitative Concept]
   737 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737 E C0700287:inform [Health Care Activity]
   737 E C1552002:inform [Idea or Concept]

Phrase: "and"

Phrase: "the possible risks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035647:Risks [Qualitative Concept]

Phrase: "associated with the study"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C2983583:Associated Study [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "before"

Phrase: "they"

Phrase: "volunteered"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0042960:Volunteer [Professional or Occupational Group]
   966   C1549078:Volunteer [Idea or Concept]
   966   C1997894:volunteer [Population Group]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate."
Processing 00000000.tx.45: The investigation was performed according to the principles outlined in the Declaration of Helsinki. 

Phrase: "The investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1261322:Investigation [Health Care Activity]
  1000   C1552578:investigation [Idea or Concept]
   928 E C1517586:Investigational [Qualitative Concept]
   928 E C3245491:investigational [Intellectual Product]

Phrase: "was"

Phrase: "performed according to the principles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0680240:according [Social Behavior]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "outlined in the Declaration of Helsinki."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0018898:Declaration of Helsinki [Regulation or Law]
           Helsinki Declaration
Processing 00000000.tx.46: Prestudy. 

Phrase: "Prestudy."
Processing 00000000.tx.47: Before the experiment, subjects participated in two preparatory tests. 

Phrase: "Before the experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "participated in two preparatory tests."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0022885:Tests [Laboratory Procedure]
   760   C0205448:Two [Quantitative Concept]
   760   C0392366:Tests [Intellectual Product]
   726 E C0039593:Test [Functional Concept]
Processing 00000000.tx.48: The first test was designed to determine one repetition maximum (1 RM). 

Phrase: "The first test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "one repetition maximum"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0806909:Maximum [Quantitative Concept]
   827   C1552615:maximum [Quantitative Concept]
   827   C2826546:MAXIMUM [Quantitative Concept]
   755 E C0205289:Maximal [Qualitative Concept]

Phrase: "(1 RM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: ")."
Processing 00000000.tx.49: During the 1 RM test, a leg press was performed at a 90180 knee angle. 

Phrase: "During the 1 RM test,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "a leg press"

Phrase: "was"

Phrase: "performed at a 90180 knee angle."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0022742:Knee [Body Part, Organ, or Organ Component]
   753   C0022745:Knee [Body Space or Junction]
   753   C0205143:Angle [Spatial Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1283838:Knee [Body Location or Region]
   753   C1963703:Knee [Body Location or Region]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.50: The load was progressively increased until the subject could not perform more than one single repetition. 

Phrase: "The load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "was"

Phrase: "progressively"

Phrase: "increased until the subject"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0681850:Subject [Group]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "more than one single repetition."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0205172:More [Functional Concept]
   760   C0205341:repetition [Functional Concept]
   760   C0205447:One [Quantitative Concept]
Processing 00000000.tx.51: The subjects reached 1 RM within 56 trials. 

Phrase: "The subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "1 RM within 56 trials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2951520:RM [Body Location or Region]
Processing 00000000.tx.52: Subjects were allowed unlimited periods of rest between trials to avoid muscle fatigue. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "unlimited periods of rest"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0260207:Rest periods [Daily or Recreational Activity]
   816   C0332188:Unlimited period [Temporal Concept]
   737   C0439531:/period [Temporal Concept]
   737   C1948053:Period [Temporal Concept]

Phrase: "between trials to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008976:Trial [Research Activity]

Phrase: "avoid"

Phrase: "muscle fatigue."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242979:Muscle Fatigue [Organ or Tissue Function]
   861   C0015672:Fatigue [Sign or Symptom]
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.53: Electromyography (EMG) electrodes (Hellige Ag/AgCl surface electrodes with diameter of recording surface 9.5 mm) were placed over the right and left vastus lateralis muscles and the hamstring muscles on the left leg. 

Phrase: "Electromyography (EMG) electrodes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013812:Electrodes [Medical Device]
   827 E C1705652:Electrode [Medical Device]

Phrase: "(Hellige Ag/AgCl surface electrodes with diameter"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0013812:Electrodes [Medical Device]
   748   C0205148:Surface [Spatial Concept]
   745   C2985511:Surface Electrode [Manufactured Object]
   714 E C1705652:Electrode [Medical Device]

Phrase: "of recording surface 9.5 mm)"

Phrase: "were"

Phrase: "placed over the right"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205090:Right [Spatial Concept]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "left vastus lateralis muscles"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   890   C0224444:Vastus lateralis muscle [Body Part, Organ, or Organ Component]
   812   C0026845:Muscles [Tissue]
   812   C1995013:Muscles [Body Part, Organ, or Organ Component]
   756   C0694662:Left vastus lateralis [Body Part, Organ, or Organ Component]
   729 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "the hamstring muscles on the left leg."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0584895:Hamstring muscles [Body Part, Organ, or Organ Component]
           Hamstring
   774   C0224456:leg muscles [Body Part, Organ, or Organ Component]
   748   C0026845:Muscles [Tissue]
   748   C1995013:Muscles [Body Part, Organ, or Organ Component]
Processing 00000000.tx.54: A telemetry EMG system (model IC-600-G, Medinik, Uppsala, Sweden) was used to record muscle activity. 

Phrase: "A telemetry EMG system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(model IC-600-G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "Medinik,"

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "record"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034869:Record [Intellectual Product]

Phrase: "muscle activity."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   964   C0231484:Muscular activity [Organ or Tissue Function]
   861   C0026845:Muscle [Tissue]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.55: A transducer (position transducer model 1850, Houston Scientific, Houston, TX) was connected between the chair and the stack wagon on the leg press machine to record the displacement amplitude and frequency of the exercise movement. 

Phrase: "A transducer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040661:Transducer [Medical Device]
  1000   C1705162:Transducer [Manufactured Object]

Phrase: "(position transducer model 1850,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0040661:Transducer [Medical Device]
   812   C0733755:Position [Spatial Concept]
   812   C1705162:Transducer [Manufactured Object]
   812   C3161035:Model [Intellectual Product]
   741 E C0240795:POSITIONAL [Finding]

Phrase: "Houston Scientific, Houston,"

Phrase: "TX)"

Phrase: "was"

Phrase: "connected between the chair"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0179847:chair [Medical Device]
   770   C1524106:Chair [Professional or Occupational Group]
   737   C2986575:Connect [Activity]

Phrase: "and"

Phrase: "the stack wagon on the leg press machine to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0336831:Wagon [Manufactured Object]

Phrase: "record"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034869:Record [Intellectual Product]

Phrase: "the displacement amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "and"

Phrase: "frequency of the exercise movement."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   844   C0556455:Frequency of exercise [Finding]
           exercise frequency
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]
Processing 00000000.tx.56: A second preparatory exercise test was performed to familiarize the subjects with the intensity and the repetition frequency of the test exercise. 

Phrase: "A second preparatory exercise test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0015260:Exercise Test [Diagnostic Procedure]
   812   C0015259:Exercise [Daily or Recreational Activity]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   812   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "familiarize"

Phrase: "the subjects with the intensity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "the repetition frequency of the test exercise."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0556455:Frequency of exercise [Finding]
           exercise frequency
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]
Processing 00000000.tx.57: During the second preparatory exercise test, subjects performed the actual standardized exercise routine scheduled to be performed during the study. 

Phrase: "During the second preparatory exercise test,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0015260:Exercise Test [Diagnostic Procedure]
   812   C0015259:Exercise [Daily or Recreational Activity]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   812   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the actual standardized exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015259:Exercise [Daily or Recreational Activity]
   827   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "routine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205547:Routine [Qualitative Concept]

Phrase: "scheduled"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086960:Scheduled [Intellectual Product]
  1000   C0205539:Scheduled [Qualitative Concept]
  1000   C1571999:Scheduled [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "performed during the study."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C0884358:Performed [Functional Concept]
   770   C2603343:Study [Research Activity]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.58: The second preparatory test was performed 2 wk before the actual exercise study. 

Phrase: "The second preparatory test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "2 wk before the actual exercise study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332174:/wk [Temporal Concept]
   748   C0439230:wk [Temporal Concept]
Processing 00000000.tx.59: Maximal oxygen uptake was determined on a mechanically braked cycle ergometer (Monark 816E, Varberg, Sweden). 

Phrase: "Maximal oxygen uptake"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   964   C0429693:Maximum oxygen uptake [Finding]
   901   C0429627:Oxygen uptake [Finding]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205289:Maximal [Qualitative Concept]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   827   C0806909:Maximal [Quantitative Concept]
   755 E C1552615:maximum [Quantitative Concept]
   755 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "was"

Phrase: "determined on a mechanically braked cycle ergometer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0180748:ergometer [Medical Device]
   748   C1511572:Cycle [Temporal Concept]
   714   C0337108:Brake [Manufactured Object]
   714   C1706206:Brake [Manufactured Object]

Phrase: "(Monark 816E,"

Phrase: "Varberg,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")."
Processing 00000000.tx.60: The work rate was gradually increased until exhaustion, as previously described (1). 

Phrase: "The work rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043227:Work [Occupational Activity]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "gradually"

Phrase: "increased until exhaustion,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205217:Increased [Quantitative Concept]
   790   C0392674:Exhaustion [Sign or Symptom]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.61: Oxygen uptake was measured using an on-line system (Amis 2001 Automated Metabolic Cart, Innovision, Odense, Denmark). 

Phrase: "Oxygen uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0429627:Oxygen uptake [Finding]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an on-line system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0029038:On-Line System [Intellectual Product,Manufactured Object]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Amis 2001 Automated Metabolic Cart,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0181813:metabolic cart [Medical Device]
   804   C0179636:Cart [Manufactured Object]
   804   C1824528:CART [Gene or Genome]

Phrase: "Innovision,"

Phrase: "Odense,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")."
Processing 00000000.tx.62: Experimental protocol. 

Phrase: "Experimental protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.63: Subjects were asked to refrain from vigorous physical activity for the 2 days before the experiment. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "asked"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "refrain from vigorous physical activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0026606:Physical activity [Daily or Recreational Activity]
   760   C0031809:Physical [Health Care Activity]
   760   C0205177:Activity [Functional Concept]
   760   C0205485:Physical [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1509143:Physical [Finding]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "for the 2 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "before the experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.64: Subjects reported to the laboratory in the morning after an overnight fast. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "reported to the laboratory"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   802   C0200370:laboratory report [Laboratory Procedure]
   802   C0551621:Laboratory report [Clinical Attribute]
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3244292:laboratory [Functional Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "in the morning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332170:Morning [Temporal Concept]

Phrase: "after an overnight fast."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015663:Fast [Finding]
   861   C0456962:Fast [Qualitative Concept]
Processing 00000000.tx.65: The subject was placed in a supine position, and a catheter was inserted into the antecubital vein for resting blood samples. 

Phrase: "The subject"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "was"

Phrase: "placed in a supine position,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0038846:Supine Position [Spatial Concept]
           Supine
   760   C0733755:Position [Spatial Concept]
   726   C0442504:Place [Spatial Concept]
   726   C1704765:Place [Functional Concept]
   726   C1882509:Place [Activity]
   726   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "a catheter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085590:Catheter [Medical Device]
  1000   C1704454:Catheter [Medical Device]

Phrase: "was"

Phrase: "inserted into the antecubital vein"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C1275965:Antecubital vein [Body Part, Organ, or Organ Component]
   806   C1276271:Antecubital vein [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C0441587:Inserted [Health Care Activity]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]
   760   C1549091:Antecubital [Body Part, Organ, or Organ Component]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "for resting blood samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0178913:blood samples [Body Substance]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.66: In one subject, in the placebo trial, the catheter was not placed in the vein because of technical difficulties, and thus venous blood samples were taken before and 2 h after the exercise by venipuncture. 

Phrase: "In one subject,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0681850:Subject [Group]
   861   C1550501:{Subject} [Idea or Concept]
   861   C1706203:Subject [Idea or Concept]
   861   C2349001:Subject [Human]
   861   C2697811:Subject [Functional Concept]

Phrase: "in the placebo trial,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008976:Trial [Research Activity]

Phrase: "the catheter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085590:Catheter [Medical Device]
  1000   C1704454:Catheter [Medical Device]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "placed in the vein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0042449:Vein [Body Part, Organ, or Organ Component]
   770   C1278960:Vein [Body Part, Organ, or Organ Component]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "because of technical difficulties,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1299586:difficulties [Finding]
   777 E C0332218:Difficult [Qualitative Concept]

Phrase: "and"

Phrase: "thus venous blood samples"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
   890   C0444255:Venous blood sample [Body Substance]
   861   C0178913:blood samples [Body Substance]
   861   C0229667:Venous blood [Tissue]
   861   C1550615:Venous Blood [Body Substance]
   861   C2338243:Venous blood [Tissue]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0042449:Venous [Body Part, Organ, or Organ Component]
   812   C0229664:Blood [Body Substance]
   812   C0348013:Venous [Spatial Concept]
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "taken before"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "2 h after the exercise"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0011744:2 H [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "by venipuncture."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0190979:VENIPUNCTURE [Diagnostic Procedure]
  1000   C0600406:venipuncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1548758:Venipuncture [Diagnostic Procedure]
Processing 00000000.tx.67: Therefore, comparisons of plasma concentration of amino acids and insulin between the two conditions were made for six subjects. 

Phrase: "Therefore,"

Phrase: "comparisons of plasma concentration of amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "insulin between the two conditions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "were"

Phrase: "made for six subjects."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205452:Six [Quantitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C1881534:Make [Functional Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.68: Muscle biopsy specimens were obtained from the lateral part of the right and left quadriceps (vastus lateralis) muscle with a Weil-Blakesley conchotome (AB Wisex, Mlndal, Sweden), as described (11). 

Phrase: "Muscle biopsy specimens"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0677862:Biopsy Specimen [Tissue]
   827   C0370003:specimens [Substance]
   793 E C2347026:Specimen [Conceptual Entity]
   734   C0185283:Muscle biopsy [Diagnostic Procedure]

Phrase: "were"

Phrase: "obtained from the lateral part of the right"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0442055:Lateral part [Spatial Concept]
   770   C1292711:Part of [Spatial Concept]
   767   C0450415:Right lateral [Spatial Concept]
   744   C0205090:Right [Spatial Concept]
   744   C0205093:Lateral [Spatial Concept]
   744   C0449719:Part [Spatial Concept]
   744   C1301820:Obtained [Functional Concept]
   744   C1709471:Part [Quantitative Concept]
   711 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "left quadriceps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0815799:Left quadriceps [Body Part, Organ, or Organ Component]
   861   C0224440:Quadriceps [Body Part, Organ, or Organ Component]

Phrase: "(vastus lateralis) muscle with a Weil-Blakesley conchotome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0224444:Vastus lateralis muscle [Body Part, Organ, or Organ Component]
           Vastus Lateralis
   770   C1321539:Vastus lateralis [Body Part, Organ, or Organ Component]
   744   C0026845:Muscle [Tissue]

Phrase: "(AB Wisex,"

Phrase: "Mlndal,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.69: Subjects exercised at 100 W for 10 min on a cycle ergometer for a warm-up bout. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "exercised at 100 W"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0015259:Exercise [Daily or Recreational Activity]
   737   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "on a cycle ergometer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0180748:ergometer [Medical Device]
   861   C1511572:Cycle [Temporal Concept]

Phrase: "for a warm-up bout."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0741605:bout [Temporal Concept]
Processing 00000000.tx.70: Thereafter, subjects were seated in the leg press machine and performed resistance exercise at a workload corresponding to 80% of 1 RM. 

Phrase: "Thereafter,"

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "seated in the leg press machine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0023216:Leg [Body Location or Region]
   753   C0277814:Seated [Finding]
   753   C0336779:Machine [Manufactured Object]
   753   C1140621:Leg [Body Location or Region]
   753   C1283233:seated [Manufactured Object]
   753   C1285009:Leg [Body Location or Region]

Phrase: "and"

Phrase: "performed resistance exercise at a workload"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0015259:Exercise [Daily or Recreational Activity]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "corresponding to 80% of 1 RM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2951520:RM [Body Location or Region]
Processing 00000000.tx.71: A metronome with a frequency of 50 beats/min, along with verbal assistance, guided the subjects to perform each repetition at a set pace so that the concentric and eccentric phases were performed for 2.4 s each. 

Phrase: "A metronome with a frequency of 50 beats/min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0870887:metronome [Manufactured Object]

Phrase: "along with verbal assistance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018896:Assistance [Social Behavior]

Phrase: "guided"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0181090:Guide [Professional or Occupational Group]
   966   C0302614:Guide [Medical Device]
   966   C1706050:Guide [Manufactured Object]

Phrase: "the subjects to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "each repetition at a set pace"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205341:repetition [Functional Concept]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the concentric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439744:Concentric [Spatial Concept]

Phrase: "and"

Phrase: "eccentric phases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0585064:Phases [Temporal Concept]
   861   C1067936:Phasis [Eukaryote]
   827 E C0205390:Phase [Temporal Concept]

Phrase: "were"

Phrase: "performed for 2.4 s"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "each."
Processing 00000000.tx.72: A short pause (1.2 s) in the movement at both the upper (knee angle 180) and lower (knee angle 90) angles of the exercise increased the subjects' ability to control the force and speed of the exercise. 

Phrase: "A short pause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0489607:pause [Temporal Concept]
   861   C1550026:Pause [Idea or Concept]

Phrase: "(1.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0580272:1/2 [Intellectual Product]
  1000   C1519043:1-2 [Research Activity]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "s) in the movement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026649:Movement [Organism Function]
   770   C2603362:S' [Clinical Attribute]

Phrase: "at both"

Phrase: "the upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: "(knee angle 180"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0022742:Knee [Body Part, Organ, or Organ Component]
   827   C0022745:Knee [Body Space or Junction]
   827   C0205143:Angle [Spatial Concept]
   827   C1283838:Knee [Body Location or Region]
   827   C1963703:Knee [Body Location or Region]

Phrase: ")"

Phrase: "and"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "(knee angle 90"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0022742:Knee [Body Part, Organ, or Organ Component]
   827   C0022745:Knee [Body Space or Junction]
   827   C0205143:Angle [Spatial Concept]
   827   C0439083:>90 [Quantitative Concept]
   827   C0439087:<90 [Quantitative Concept]
   827   C1283838:Knee [Body Location or Region]
   827   C1963703:Knee [Body Location or Region]

Phrase: ")"

Phrase: "angles of the exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C0205143:Angle [Spatial Concept]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the subjects' ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the force"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441722:Force [Phenomenon or Process]
  1000   C0563538:Force [Phenomenon or Process]
   944 E C0729333:Dynamic [Functional Concept]

Phrase: "and"

Phrase: "speed of the exercise."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678536:Speed [Quantitative Concept]
Processing 00000000.tx.73: The protocol consisted of four sets of 10 repetitions, with a 5-min rest between sets. 

Phrase: "The protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "consisted of four sets of 10 repetitions,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0036849:Set [Mental Process]
   748   C0205341:repetitions [Functional Concept]
   748   C0205450:Four [Quantitative Concept]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]
   714   C0332529:CONSIST [Qualitative Concept]

Phrase: "with a 5-min rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035253:Rest [Daily or Recreational Activity]
   827   C1622890:ResT [Molecular Function]

Phrase: "between sets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.74: Thus the resistance exercise protocol lasted for a total of 20 min. 

Phrase: "Thus"

Phrase: "the resistance exercise protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]

Phrase: "lasted for a total of 20 min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0702093:/min [Temporal Concept]
   714   C1517741:Last [Qualitative Concept]
Processing 00000000.tx.75: Blood samples were taken at rest (before the warm-up and before any drink was supplied), immediately before resistance exercise, during resistance exercise at 10 min, immediately after resistance exercise, and during recovery at 15, 30, 60, 90 and 120 min after resistance exercise. 

Phrase: "Blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "taken at rest"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1622890:ResT [Molecular Function]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]

Phrase: "("

Phrase: "before the warm-up"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0687712:warm [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "before"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "any drink"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0452428:Drink [Food]

Phrase: "was"

Phrase: "supplied"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1999230:Supplied [Activity]
   966 E C0243163:supply [Idea or Concept]
   966 E C0699914:supply [Quantitative Concept]
   966 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   966 E C1561604:supply [Functional Concept]
   966 E C1875802:SUPPLY [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "before"

Phrase: "resistance exercise,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "during resistance exercise"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "at 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "resistance exercise,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and during recovery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0237820:Recovery [Activity]
   790   C1515981:And [Idea or Concept]
   790   C1555688:recovery [Idea or Concept]
   790   C2004454:Recovery [Organism Function]

Phrase: "at 15,"

Phrase: "30,"

Phrase: "60,"

Phrase: "90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "and"

Phrase: "120 min after resistance exercise."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]
Processing 00000000.tx.76: Muscle biopsy specimens were taken at rest (before the warm-up period), immediately after resistance exercise, and during recovery at 1 and 2 h after resistance exercise. 

Phrase: "Muscle biopsy specimens"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0677862:Biopsy Specimen [Tissue]
   827   C0370003:specimens [Substance]
   793 E C2347026:Specimen [Conceptual Entity]
   734   C0185283:Muscle biopsy [Diagnostic Procedure]

Phrase: "were"

Phrase: "taken at rest"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C1622890:ResT [Molecular Function]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]

Phrase: "("

Phrase: "before the warm-up period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "resistance exercise,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and during recovery at 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237820:Recovery [Activity]
   760   C1515981:And [Idea or Concept]
   760   C1555688:recovery [Idea or Concept]
   760   C2004454:Recovery [Organism Function]

Phrase: "and"

Phrase: "2 h after resistance exercise."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0011744:2 H [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.77: The first and third biopsies were taken from the right vastus lateralis muscle, and the second and fourth biopsies were taken from the left vastus lateralis muscle. 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "third biopsies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0005558:biopsies [Diagnostic Procedure]
   827 E C0220797:biopsy [Functional Concept]

Phrase: "were"

Phrase: "taken from the right vastus lateralis muscle,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   814   C0224444:Vastus lateralis muscle [Body Part, Organ, or Organ Component]
           Vastus Lateralis
   814   C0694678:Right vastus lateralis [Body Part, Organ, or Organ Component]
   778   C1321539:Vastus lateralis [Body Part, Organ, or Organ Component]
   748   C0026845:Muscle [Tissue]
   748   C0205090:Right [Spatial Concept]
   748   C1883727:Taken [Conceptual Entity]
   714 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "the second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "fourth biopsies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0005558:biopsies [Diagnostic Procedure]
   827 E C0220797:biopsy [Functional Concept]

Phrase: "were"

Phrase: "taken from the left vastus lateralis muscle."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   814   C0224444:Vastus lateralis muscle [Body Part, Organ, or Organ Component]
           Vastus Lateralis
   814   C0694662:Left vastus lateralis [Body Part, Organ, or Organ Component]
   778   C1321539:Vastus lateralis [Body Part, Organ, or Organ Component]
   748   C0026845:Muscle [Tissue]
   748   C0205091:Left [Spatial Concept]
   748   C1552822:left [Functional Concept]
   748   C1883727:Taken [Conceptual Entity]
   714 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.78: The second biopsy in each leg was taken 5 cm proximal to the first biopsy. 

Phrase: "The second biopsy in each leg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005558:Biopsy [Diagnostic Procedure]
   753   C0220797:biopsy [Functional Concept]

Phrase: "was"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "5 cm"

Phrase: "proximal to the first biopsy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205107:Proximal [Spatial Concept]
Processing 00000000.tx.79: Subjects ingested a 150-ml solution of either a mixture of the three BCAA (45% leucine, 30% valine, and 25% isoleucine; Ajinomoto, Kanagawa, Japan) or flavored water before the warm-up exercise, immediately before the resistance exercise, during resistance exercise at 15 min, and during recovery at 15, 30, 60, and 90 min after resistance exercise. 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "ingested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232478:Ingested [Biologic Function]

Phrase: "a 150-ml solution of either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]

Phrase: "a mixture of the three BCAA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439962:Mixture [Substance]

Phrase: "(45% leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "30% valine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "25% isoleucine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "; Ajinomoto,"

Phrase: "Kanagawa,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "or"

Phrase: "flavored water before the warm-up exercise,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   748   C0599638:WATER [Substance]
   748   C1550678:Water [Inorganic Chemical]

Phrase: "immediately before the resistance exercise,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0015259:Exercise [Daily or Recreational Activity]
   760   C0205548:Immediately [Temporal Concept]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "during resistance exercise"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "at 15 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and during recovery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0237820:Recovery [Activity]
   790   C1515981:And [Idea or Concept]
   790   C1555688:recovery [Idea or Concept]
   790   C2004454:Recovery [Organism Function]

Phrase: "at 15,"

Phrase: "30,"

Phrase: "60,"

Phrase: "and"

Phrase: "90 min after resistance exercise."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0702093:/min [Temporal Concept]
Processing 00000000.tx.80: Both drinks contained lemon flavor, salts, citric acid, and an artificial sweetener. 

Phrase: "Both"

Phrase: "drinks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0452428:Drink [Food]

Phrase: "contained lemon flavor,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0475657:Lemon flavor [Food]
   827   C0475332:FLAVOR [Substance]
   827   C0596585:flavor [Qualitative Concept]
   827   C0699771:flavor [Organ or Tissue Function]

Phrase: "salts,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0036140:Salts [Chemical Viewed Structurally]
   966 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   966 E C0206136:Salt [Food,Inorganic Chemical]
   916 E C1537053:salty [Qualitative Concept]
   893 E C0678584:saltiness [Qualitative Concept]

Phrase: "citric acid,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0055819:Citric Acid [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
           citric
  1000   C1171556:citric acid [Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "an artificial sweetener."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003920:Artificial sweetener [Food]
   861   C0038998:Sweetener [Chemical Viewed Functionally]
   861   C1705222:Sweetener [Biomedical or Dental Material]
   861   C2004457:Artificial [Qualitative Concept]
Processing 00000000.tx.81: The two drinks were indistinguishable in taste. 

Phrase: "The two drinks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0452428:Drinks [Food]

Phrase: "were"

Phrase: "indistinguishable in taste."
Processing 00000000.tx.82: The subjects were provided a total of 100 mg of BCAA/kg body wt in 1,050 ml of flavored water. 

Phrase: "The subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "a total of 100 mg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "of BCAA/kg body wt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C2700323:WT [Fish]
   710   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in 1,050 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "of flavored water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.83: The amount of BCAA and the composition of the BCAA mixture were the same as in a previous study (4). 

Phrase: "The amount of BCAA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "the composition of the BCAA mixture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0486616:Composition [Clinical Attribute]
   742   C1555710:composition [Idea or Concept]

Phrase: "were"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "as in a previous study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205156:Previous [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1552607:previous [Temporal Concept]
   760   C2603343:Study [Research Activity]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.84: The experiment was designed as a double-blind crossover test. 

Phrase: "The experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "designed as a double-blind crossover test."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   778   C0013072:DOUBLE BLIND [Research Activity]
   778   C0431012:Crossover test [Laboratory Procedure]
   774   C0554818:Double test [Laboratory Procedure]
   757   C0242817:Cross-Over Design [Research Activity]
   748   C0010366:cross over [Genetic Function]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0150097:CROSS-OVER [Research Activity]
   748   C0150108:Blind [Research Activity]
   748   C0205173:Double [Functional Concept]
   748   C0392366:test [Intellectual Product]
   748   C0456909:Blind [Disease or Syndrome]
   748   C0525065:blind [Patient or Disabled Group]
   748   C1705764:Double [Activity]
   748   C1705765:Double [Qualitative Concept]
   714   C1707689:Design [Activity]
   714   C2983265:DESIGN [Intellectual Product]
Processing 00000000.tx.85: The two experiments were performed with a 1-mo interval between them. 

Phrase: "The two experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed with a 1-mo interval"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0884358:Performed [Functional Concept]
   753   C1272706:Interval [Temporal Concept]
   753   C1552654:Interval [Idea or Concept]
   753   C1552713:Interval [Intellectual Product]
   753   C3538743:MO [Idea or Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "between them."
Processing 00000000.tx.86: Four subjects were supplied BCAA solution in the first experiment and placebo in the second; 

Phrase: "Four subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "supplied"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1999230:Supplied [Activity]
   966 E C0243163:supply [Idea or Concept]
   966 E C0699914:supply [Quantitative Concept]
   966 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   966 E C1561604:supply [Functional Concept]
   966 E C1875802:SUPPLY [Medical Device]

Phrase: "BCAA solution in the first experiment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C0308312:AMINO ACID SOLUTION [Clinical Drug]
   742   C0037633:Solution [Substance]
   742   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "placebo in the second"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032042:placebo [Therapeutic or Preventive Procedure]
   770   C1696465:placebo [Biomedical or Dental Material]
   770   C1706408:PLACEBO [Research Activity]

Phrase: ";"
Processing 00000000.tx.87: consequently, three subjects were supplied with placebo in the first and BCAA in the second experiment. 

Phrase: "consequently,"

Phrase: "three subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "supplied with placebo"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0032042:placebo [Therapeutic or Preventive Procedure]
   790   C1696465:placebo [Biomedical or Dental Material]
   790   C1706408:PLACEBO [Research Activity]
   790   C1999230:Supplied [Activity]
   756 E C0243163:supply [Idea or Concept]
   756 E C0699914:supply [Quantitative Concept]
   756 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   756 E C1561604:supply [Functional Concept]
   756 E C1875802:SUPPLY [Medical Device]

Phrase: "in the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "BCAA in the second experiment."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   833   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C0020931:Amino Acids, Secondary [Amino Acid, Peptide, or Protein]
   744   C0001128:Acids [Chemical]
   744   C0337112:Chain [Manufactured Object]
   744   C1253959:branched [Body Part, Organ, or Organ Component]
   744   C1524075:Chain [Idea or Concept]
   744   C2700384:Branched [Spatial Concept]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C1881507:Branch [Chemical Viewed Structurally]
   711 E C2700383:Branch [Plant]
   711 E C2826234:BRANCH [Intellectual Product]
Processing 00000000.tx.88: Blood chemistry. 

Phrase: "Blood chemistry."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005774:Blood chemistry [Laboratory Procedure]
   861   C0007996:Chemistry [Occupation or Discipline]
   861   C0079107:chemistry [Classification]
   861   C0201682:Chemistry [Laboratory Procedure]
Processing 00000000.tx.89: Blood samples were taken from the venous catheter and divided into two different glass tubes; 

Phrase: "Blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "taken from the venous catheter"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0745442:Venous catheter [Medical Device]
   760   C0042449:Venous [Body Part, Organ, or Organ Component]
   760   C0085590:Catheter [Medical Device]
   760   C0348013:Venous [Spatial Concept]
   760   C1704454:Catheter [Medical Device]
   760   C1883727:Taken [Conceptual Entity]
   726 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "divided into two different glass tubes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   773   C0336635:Glass tube [Medical Device]
   753   C0017596:Glass [Manufactured Object]
   753   C0175730:tubes [Medical Device]
   753   C0205448:Two [Quantitative Concept]
   753   C0332849:Divided [Functional Concept]
   753   C1547937:Tubes [Intellectual Product]
   753   C1704474:Tubes [Quantitative Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C1947936:Glass [Medical Device]
   719 E C1561954:tube [Conceptual Entity]
   719 E C1704730:TUBE [Medical Device]

Phrase: ";"
Processing 00000000.tx.90: one was heparinized for amino acid measurements, and one contained EDTA for measurements of insulin. 

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "heparinized for amino acid measurements,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   845   C0201874:Amino Acid Measurement [Laboratory Procedure]
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0242485:measurements [Functional Concept]

Phrase: "and"

Phrase: "one contained EDTA for measurements of insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.91: The tubes were centrifuged (6,000 rpm for 2 min), and plasma was stored at 80C. 

Phrase: "The tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0175730:tubes [Medical Device]
  1000   C1547937:Tubes [Intellectual Product]
  1000   C1704474:Tubes [Quantitative Concept]
   966 E C1561954:tube [Conceptual Entity]
   966 E C1704730:TUBE [Medical Device]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(6,000 rpm for 2 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0582523:rpm [Quantitative Concept]

Phrase: "and"

Phrase: "plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "was"

Phrase: "stored at 80C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.92: For amino acid determinations, plasma samples were deproteinized with 5% trichloroacetic acid (1:5) and centrifuged at 9,000 g for 2 min. 

Phrase: "For amino acid determinations,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "plasma samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444263:Plasma sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "deproteinized with 5% trichloroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "centrifuged at 9,000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 2 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.93: The supernatant was stored at 80C until analyzed. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "stored at 80C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]

Phrase: "until"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.94: The concentration of amino acids was measured by reversed-phase HPLC, as described (21), with orthophthaldialdehyde as the derivatizing agent. 

Phrase: "The concentration of amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "measured by reversed-phase HPLC,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C1555029:Reverse [Idea or Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "with orthophthaldialdehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028752:Orthophthaldialdehyde [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "as the derivatizing agent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450442:Agent [Chemical Viewed Functionally]
   861   C1254351:Agent [Pharmacologic Substance]
   861   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.95: Plasma insulin concentration was measured with a radioimmunoassay (Linco Research, St. Charles, MO). 

Phrase: "Plasma insulin concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0683150:plasma concentration [Quantitative Concept]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0857690:plasma insulin [Laboratory Procedure]

Phrase: "was"

Phrase: "measured with a radioimmunoassay"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0034580:Radioimmunoassay [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(Linco Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "St. Charles,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.96: Tissue processing. 

Phrase: "Tissue processing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1328957:tissue processing [Laboratory Procedure]
   861   C1709694:Processing [Activity]
Processing 00000000.tx.97: Muscle biopsies (30100 mg) were cleaned of visible surface blood and placed in liquid nitrogen. 

Phrase: "Muscle biopsies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0185283:Muscle biopsy [Diagnostic Procedure]
   861   C0005558:biopsies [Diagnostic Procedure]
   827 E C0220797:biopsy [Functional Concept]

Phrase: "(30100 mg)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "were"

Phrase: "cleaned of visible surface blood"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0205148:Surface [Spatial Concept]
   760   C0205379:Visible [Qualitative Concept]
   760   C0229664:Blood [Body Substance]
   760   C1947930:Cleaned [Activity]

Phrase: "and"

Phrase: "placed in liquid nitrogen."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.98: Samples were freeze-dried and homogenized in 90 l/mg dry wt ice-cold buffer (137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 0.5 mM Na3VO4, 1% Triton X-100, 7.5% glycerol, 20 mM Tris pH 8.0, 5 g/l leupeptin, 1 mM phenylmethylsulfonyl fluoride, and 10 mM NaF). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "freeze-dried"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0016698:freeze-dried [Laboratory Procedure]
   861   C0016701:Freeze [Natural Phenomenon or Process]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "homogenized in 90 l/mg dry wt ice-cold buffer"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   760   C0456963:Ice cold [Qualitative Concept]
   757   C0013239:Dry Ice [Inorganic Chemical]
   757   C0439268:mg/L [Quantitative Concept]
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0009264:Cold [Natural Phenomenon or Process]
   739   C0009443:Cold [Disease or Syndrome]
   739   C0011682:Dry [Natural Phenomenon or Process]
   739   C0020746:Ice [Inorganic Chemical]
   739   C0205222:Dry [Qualitative Concept]
   739   C0234192:Cold [Physiologic Function]
   739   C0439083:>90 [Quantitative Concept]
   739   C0439087:<90 [Quantitative Concept]
   739   C0439269:mg% [Quantitative Concept]
   739   C1512080:Dry [Qualitative Concept]
   739   C1960952:mg % [Quantitative Concept]
   739   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C2700323:WT [Fish]

Phrase: "(137 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "2.7 mM KCl,"

Phrase: "1 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.5 mM Na3VO4,"

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "7.5% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "20 mM Tris pH 8.0,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0020283:[pH] [Quantitative Concept]
   799   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C0814229:TRI [Intellectual Product]

Phrase: "5 g/l leupeptin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "1 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "10 mM NaF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.99: Homogenates were rotated for 30 min and centrifuged at 12,000 g for 10 min at 4C. 

Phrase: "Homogenates"

Phrase: "were"

Phrase: "rotated for 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0231458:Rotated [Spatial Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "centrifuged at 12,000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.100: Protein was determined in aliquots of the supernatant using a Bradford protein assay (Bio-Rad Laboratories, Richmond, CA). 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "determined in aliquots of the supernatant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1550101:Supernatant [Body Substance]
   719   C1510844:Aliquot [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bradford protein assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(Bio-Rad Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Richmond,"

Phrase: "CA)."
Processing 00000000.tx.101: Immunoblot analysis. 

Phrase: "Immunoblot analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.102: Aliquots of muscle lysate were solubilized in Laemmli sample buffer (45 g protein phosphorylation or 300 g for gel mobility shift assay), and proteins were separated by SDS-PAGE. 

Phrase: "Aliquots of muscle lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "solubilized in Laemmli sample buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0258024:Laemmli buffer [Organic Chemical]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "(45 g protein phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   812   C0031715:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "300 g for gel mobility shift assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by SDS-PAGE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]
Processing 00000000.tx.103: After gel electrophoresis, proteins were transferred to polyvinylidene fluoride or nitrocellulose membranes for S6 phosphorylation (Bio-Rad Laboratories). 

Phrase: "After gel electrophoresis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596607:Gel Electrophoresis [Laboratory Procedure]
   861   C0013855:Electrophoresis [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred to polyvinylidene fluoride"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0071710:polyvinylidene fluoride [Organic Chemical]
   770   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "or"

Phrase: "nitrocellulose membranes for S6 phosphorylation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "(Bio-Rad Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: ")."
Processing 00000000.tx.104: Membranes were blocked in Tris-buffered saline (TBS; 10 mM Tris, pH 7.6, and 100 mM NaCl) containing 5% nonfat milk for 1 h at room temperature and then incubated for 2 h at room temperature with primary antibodies. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "blocked in Tris-buffered saline"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0028778:Blocked [Pathologic Function]
   760   C0036082:Saline [Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0332206:Blocked [Functional Concept]
   760   C0814229:TRI [Intellectual Product]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "(TBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "; 10 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "100 mM NaCl)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% nonfat milk for 1 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0026131:Milk [Body Substance]
   753   C0349374:Milk [Food]
   753   C0444318:Milk [Substance]
   753   C2825079:Milk [Food]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 2 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "with primary antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.105: For phosphorylation determinations, membranes were incubated with commercially available phosphospecific antibodies that recognize p70S6k phosphorylated at Ser424/Thr421, ERK1/2 (p44/p42) MAPK phosphorylated at Thr202/Tyr204, p38 MAPK phosphorylated at Thr180/Tyr182, S6 phosphorylated at Ser235/Ser236 (Cell Signaling Technology, Beverly, MA), and p70S6k phosphorylated at Thr389 (Santa Cruz Biotechnology, Santa Cruz, CA). 

Phrase: "For phosphorylation determinations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with commercially available phosphospecific antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1257988:Antibodies, Phospho-Specific [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0470187:Available [Functional Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "recognize"

Phrase: "p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "phosphorylated at Ser424/Thr421,"

Phrase: "ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(p44/p42"

Phrase: ")"

Phrase: "MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "phosphorylated at Thr202/Tyr204,"

Phrase: "p38 MAPK"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "phosphorylated at Thr180/Tyr182,"

Phrase: "S6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1419024:S6 [Gene or Genome]
  1000   C1419741:S6 [Gene or Genome]
  1000   C1861424:S6 [Gene or Genome]
  1000   C2348600:S6+ [Element, Ion, or Isotope]

Phrase: "phosphorylated at Ser235/Ser236"

Phrase: "(Cell Signaling Technology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039421:Technology [Occupation or Discipline]
   734   C0037083:Cell Signaling [Cell Function]

Phrase: "Beverly,"

Phrase: "MA"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "phosphorylated at Thr389"

Phrase: "(Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA)."
Processing 00000000.tx.106: For the p70S6k gel mobility shift assay, membranes were incubated with a polyclonal antibody that recognizes p70S6k protein (New England Biolabs, Beverly, MA). 

Phrase: "For the p70S6k gel mobility shift assay,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   937   C0596608:gel mobility shift assay [Diagnostic Procedure]
   888   C0949632:Gel Shift Assay [Laboratory Procedure]
           Mobility Shift Assay
   804   C0005507:Assay [Laboratory Procedure]
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C0243073:assay [Qualitative Concept]
   804   C0333051:Shift [Functional Concept]
   804   C0425245:Mobility [Finding]
   804   C0449580:Mobility [Qualitative Concept]
   804   C1382104:Gel [Substance]
   804   C1510438:Assay [Laboratory Procedure]
   804   C2347509:Shift [Phenomenon or Process]
   733 E C0231435:Mobile [Functional Concept]
   733 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with a polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "that"

Phrase: "recognizes"

Phrase: "p70S6k protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(New England Biolabs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: "Beverly,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.107: After incubation with primary antibodies, membranes were washed with TBS, containing 0.1% Tween 20 (TBST) and with 2.5% nonfat dry milk added, and incubated with appropriate secondary antibody for 1 h at room temperature, followed by washing in TBST. 

Phrase: "After incubation"

Phrase: "with primary antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "washed with TBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C1532188:Tbsp [Quantitative Concept]
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Tween 20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "(TBST"

Phrase: ")"

Phrase: "and with 2.5% nonfat dry milk"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0011682:Dry [Natural Phenomenon or Process]
   748   C0026131:Milk [Body Substance]
   748   C0205222:Dry [Qualitative Concept]
   748   C0349374:Milk [Food]
   748   C0444318:Milk [Substance]
   748   C1512080:Dry [Qualitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C2825079:Milk [Food]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "incubated with appropriate secondary antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0027627:secondary [Neoplastic Process]
   760   C0175668:Secondary [Temporal Concept]
   760   C0205436:Secondary [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1548787:Appropriate [Qualitative Concept]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "followed by washing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0441648:Washing [Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in TBST."
Processing 00000000.tx.108: Proteins were visualized by enhanced chemiluminescence reagents (Amersham Pharmacia Biotech, Uppsala, Sweden) and quantified by densitometric scanning with a Gel Doc 1000, in combination with Molecular Analyst software (version 1.5; Bio-Rad Laboratories). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "visualized by enhanced chemiluminescence reagents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   760   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   760   C0234621:Visualized [Functional Concept]
   760   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   760   C2349975:Enhanced [Activity]

Phrase: "(Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "quantified by densitometric scanning"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0011321:densitometric scanning [Laboratory Procedure]
   770   C0034606:Scanning [Diagnostic Procedure]
   770   C0441633:Scanning [Diagnostic Procedure]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "with a Gel Doc 1000,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C1301746:Doc [Intellectual Product]
   827   C1382104:Gel [Substance]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with Molecular Analyst software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(version 1.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "; Bio-Rad Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: ")."
Processing 00000000.tx.109: The membranes described above were incubated in buffer (TrisHCl pH 6.7, 2% SDS, and 100 M -mercaptoethanol) for 30 min at 60C and reprobed to confirm equal sample loading. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "were"

Phrase: "incubated in buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "(TrisHCl pH 6.7,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1882074:pH 7 [Qualitative Concept]
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]

Phrase: "2% SDS,"

Phrase: "and"

Phrase: "100"

Phrase: "M -"

Phrase: "mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 60C"

Phrase: "and"

Phrase: "reprobed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "equal sample loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708715:Loading [Activity]
Processing 00000000.tx.110: Protein expression of p70S6k, ERK1/2 MAPK, p38 MAPK, and S6 was determined by immunoblot analysis, as described above, with the respective polyclonal antibodies (Cell Signaling Technology). 

Phrase: "Protein expression of p70S6k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1171362:protein expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "ERK1/2 MAPK,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   895   C0082529:ERK1 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0026249:Mitogen [Pharmacologic Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1879547:Activated [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: "p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "S6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1419024:S6 [Gene or Genome]
  1000   C1419741:S6 [Gene or Genome]
  1000   C1861424:S6 [Gene or Genome]
  1000   C2348600:S6+ [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "determined by immunoblot analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "as"

Phrase: "described above,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "with the respective polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Cell Signaling Technology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039421:Technology [Occupation or Discipline]
   734   C0037083:Cell Signaling [Cell Function]

Phrase: ")."
Processing 00000000.tx.111: Statistics. 

Phrase: "Statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.112: All data are presented as means  SE. 

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as means  SE."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0449450:Presented [Idea or Concept]
   770   C1704970:Means [Conceptual Entity]
   737 E C0150312:Present [Quantitative Concept]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.113: Differences between BCAA and placebo conditions for plasma concentrations of insulin and amino acids during exercise and recovery were evaluated by comparing the corresponding areas under the time vs. concentration curves. 

Phrase: "Differences between BCAA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]
   716   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "conditions for plasma concentrations of insulin"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   783   C0683150:concentrations plasma [Quantitative Concept]
   783   C0857690:plasma insulin [Laboratory Procedure]
   753   C0012634:condition [Disease or Syndrome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0032105:Plasma [Body Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C0348080:Condition [Qualitative Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1705253:Condition [Conceptual Entity]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "amino acids during exercise"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799 E C2917660:Amino Acid [Pharmacologic Substance]
   770   C0001128:Acids [Chemical]
   737 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "were"

Phrase: "evaluated by comparing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0220825:Evaluated [Functional Concept]
   756   C1707455:Compare [Activity]

Phrase: "the corresponding areas under the time"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0205146:areas [Spatial Concept]
   719 E C0017446:Area [Geographic Area]

Phrase: "vs. concentration curves."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205134:Curve [Spatial Concept]
Processing 00000000.tx.114: The concentrations at two consecutive time points were averaged, multiplied by the time span, and summed for the whole exercise or recovery period. 

Phrase: "The concentrations at two consecutive time points"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: ","

Phrase: "multiplied by the time span,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0040223:Time [Temporal Concept]
   760   C1711300:Span [Conceptual Entity]
   760   C2700613:Span [Quantitative Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1719797:Multiply [Functional Concept]
   726   C2911648:Multiply [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "summed for the whole exercise"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0015259:Exercise [Daily or Recreational Activity]
   760   C0444667:Whole [Quantitative Concept]
   760   C1522704:Exercise [Therapeutic or Preventive Procedure]
   726   C1515051:Sum [Quantitative Concept]

Phrase: "or"

Phrase: "recovery period."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2983655:Recovery Period [Temporal Concept]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.115: The comparison between the areas was then made by Student's t-test for paired observations. 

Phrase: "The comparison between the areas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "made by Student's t-test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]
   726   C1881534:Make [Functional Concept]

Phrase: "for paired observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.116: A two-factorial (time, supplement) repeated-measures ANOVA was employed to compare changes in phosphorylation in skeletal muscle samples between the BCAA and placebo treatments. 

Phrase: "A two-factorial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826344:FACTORIAL [Research Activity]

Phrase: "(time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "supplement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242295:Supplement [Food]
  1000   C1947943:Supplement [Intellectual Product]
  1000   C2348609:Supplement [Functional Concept]

Phrase: ")"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "-"

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "ANOVA"

Phrase: "was"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "changes in phosphorylation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in skeletal muscle samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C0242692:Muscle, Skeletal [Tissue]
   734   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]

Phrase: "between the BCAA"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "and"

Phrase: "placebo treatments."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.117: When a significant overall effect was indicated, a Pair-Wise Contrasts post hoc test was performed. 

Phrase: "When"

Phrase: "a significant overall effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "a Pair-Wise"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1427738:WISE [Gene or Genome]
   861   C1709450:Pair [Qualitative Concept]
   789 E C0871611:wisdom [Idea or Concept]

Phrase: "Contrasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "post hoc test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.118: Significance was accepted at P < 0.05. 

Phrase: "Significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "accepted at P < 0.05."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   726 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.119: RESULTS Four subjects performed the stipulated 4 x 10 repetitions in both trials. 

Phrase: "RESULTS Four subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the stipulated 4 x 10 repetitions in both trials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205341:repetitions [Functional Concept]
Processing 00000000.tx.120: The remaining three subjects did not complete the entire protocol; 

Phrase: "The remaining three subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "the entire protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.121: two subjects performed 12 fewer repetitions on one occasion, and one subject performed 1011 fewer repetitions on both trials. 

Phrase: "two subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "12 fewer repetitions on one occasion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205341:repetitions [Functional Concept]

Phrase: "and"

Phrase: "one subject"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0681850:Subject [Group]
   861   C1550501:{Subject} [Idea or Concept]
   861   C1706203:Subject [Idea or Concept]
   861   C2349001:Subject [Human]
   861   C2697811:Subject [Functional Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "1011 fewer repetitions on both trials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205341:repetitions [Functional Concept]
Processing 00000000.tx.122: EMG activity recorded during the first pretest revealed increased activity of the vastus lateralis muscle of both legs during repeated contractions at 80% of 1 RM with relatively little activation of the hamstring muscle (Fig. 1). 

Phrase: "EMG activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "recorded during the first pretest"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033101:pretest [Health Care Activity]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   726   C0034869:Record [Intellectual Product]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "increased activity of the vastus lateralis muscle of both legs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0474395:increased activity [Finding]
   751   C0231487:Increased muscular activity [Finding]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]
   722   C0231484:Muscular activity [Organ or Tissue Function]

Phrase: "during repeated contractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1140999:contractions [Pathologic Function]

Phrase: "at 80%"

Phrase: "of 1 RM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "with relatively little activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "of the hamstring muscle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0584895:Hamstring muscle [Body Part, Organ, or Organ Component]
           Hamstring
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.123: View larger version (40K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.124: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.125: Recording of electromyographic (EMG) activity (arbitrary units) in vastus lateralis muscle (VL dxt and VL sin, right and left legs) and hamstring muscle (Ham sin, left leg), and displacement during concentric and eccentric action from 1 subject during repeated contractions during the prestudy trial. 

Phrase: "Recording of electromyographic"

Phrase: "(EMG"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013839:Electromyography [Diagnostic Procedure]
   900 E C0180677:Electromyographs [Medical Device]

Phrase: ")"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "(arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: "in vastus lateralis muscle"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0224444:Vastus lateralis muscle [Body Part, Organ, or Organ Component]
           Vastus Lateralis
   901   C1321539:Vastus lateralis [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "(VL dxt"

Phrase: "and"

Phrase: "VL sin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "left legs"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0230443:left legs [Body Part, Organ, or Organ Component]
   966 E C1279606:Left leg [Body Part, Organ, or Organ Component]
   861   C0205091:Left [Spatial Concept]
   861   C1140621:Legs [Body Location or Region]
   861   C1552822:left [Functional Concept]
   827 E C0023216:Leg [Body Location or Region]
   827 E C1285009:Leg [Body Location or Region]

Phrase: ")"

Phrase: "and"

Phrase: "hamstring muscle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0584895:Hamstring muscle [Body Part, Organ, or Organ Component]
           Hamstring
   861   C0026845:Muscle [Tissue]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "(Ham sin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "left leg"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0230443:Left leg [Body Part, Organ, or Organ Component]
  1000   C1279606:Left leg [Body Part, Organ, or Organ Component]
   861   C0023216:Leg [Body Location or Region]
   861   C0205091:Left [Spatial Concept]
   861   C1140621:Leg [Body Location or Region]
   861   C1285009:Leg [Body Location or Region]
   861   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "displacement during concentric"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0012725:Displacement [Mental Process]
   790   C0012727:Displacement [Spatial Concept]
   790   C0456080:Displacement [Qualitative Concept]
   790   C2347509:Displacement [Phenomenon or Process]

Phrase: "and"

Phrase: "eccentric action from 1 subject"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "during repeated contractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1140999:contractions [Pathologic Function]

Phrase: "during the prestudy trial."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008976:Trial [Research Activity]
Processing 00000000.tx.126: Right vertical bar denotes EMG amplitude at isometric maximal voluntary contraction (EMG IMVC).  

Phrase: "Right vertical bar"

Phrase: "denotes"

Phrase: "EMG amplitude at isometric maximal voluntary contraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0429340:Electromyography amplitude [Finding]
   748   C2346753:Amplitude [Spatial Concept]

Phrase: "(EMG IMVC"

Phrase: ")."
Processing 00000000.tx.127: Ingestion of BCAA led to an increase in the plasma concentration of these amino acids, with levels still elevated 50110% during the 2-h recovery period (Fig. 2). 

Phrase: "Ingestion of BCAA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0237965:ACID INGESTION [Injury or Poisoning]
   753   C0232478:Ingestion [Biologic Function]
   716   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "led to an increase"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the plasma concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0683150:plasma concentration [Quantitative Concept]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of these amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "with levels still"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "50110% during the 2-h recovery period"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C2983655:Recovery Period [Temporal Concept]
   774   C0011744:h 2 [Element, Ion, or Isotope]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0237820:Recovery [Activity]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439531:/period [Temporal Concept]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C1555688:recovery [Idea or Concept]
   748   C1948053:Period [Temporal Concept]
   748   C2004454:Recovery [Organism Function]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.128: The individual BCAA, isoleucine, leucine, and valine (Table 1), were significantly elevated during and after exercise. 

Phrase: "The individual BCAA,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   937   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   804   C0337112:Chain [Manufactured Object]
   804   C1253959:branched [Body Part, Organ, or Organ Component]
   804   C1524075:Chain [Idea or Concept]
   804   C2700384:Branched [Spatial Concept]
   771 E C0202406:Acid [Laboratory Procedure]
   771 E C1881507:Branch [Chemical Viewed Structurally]
   771 E C2700383:Branch [Plant]
   771 E C2826234:BRANCH [Intellectual Product]

Phrase: "isoleucine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "valine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "significantly"

Phrase: "elevated during"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205250:Elevated [Qualitative Concept]
   833   C3163633:Elevated [Qualitative Concept]

Phrase: "and after exercise."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.129: Resistance exercise increased plasma insulin concentration in all subjects during the placebo and BCAA trials, respectively (Fig. 3). 

Phrase: "Resistance exercise increased plasma insulin concentration in all"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0683150:concentration plasma [Quantitative Concept]
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "subjects during the placebo"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0032042:placebo [Therapeutic or Preventive Procedure]
   770   C0681850:Subject [Group]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1696465:placebo [Biomedical or Dental Material]
   770   C1706203:Subject [Idea or Concept]
   770   C1706408:PLACEBO [Research Activity]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "BCAA trials,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0008976:Trial [Research Activity]

Phrase: "respectively"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.130: However, the change in plasma insulin concentration during exercise was not significantly different between placebo and BCAA trials. 

Phrase: "However,"

Phrase: "the change in plasma insulin concentration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025320:The change [Physiologic Function]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "during exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not significantly different between placebo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "BCAA trials."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0008976:Trial [Research Activity]
Processing 00000000.tx.131: Although plasma insulin concentration was significantly higher during the BCAA trial 2-h recovery period after exercise, this increase is unlikely to be physiologically relevant, because this particular parameter was within normal variability. 

Phrase: "Although"

Phrase: "plasma insulin concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0683150:plasma concentration [Quantitative Concept]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0857690:plasma insulin [Laboratory Procedure]

Phrase: "was"

Phrase: "significantly higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "during the BCAA trial 2-h recovery period"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   807   C2983655:Recovery Period [Temporal Concept]
   791   C0439531:/period [Temporal Concept]
   791   C1948053:Period [Temporal Concept]
   720 E C0332182:Periodic [Temporal Concept]
   720 E C1706381:PERIODIC [Intellectual Product]

Phrase: "after exercise,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "this increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "be"

Phrase: "physiologically relevant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]

Phrase: "because"

Phrase: "this particular parameter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0549193:Parameter [Spatial Concept]
   861   C1704769:Parameter [Conceptual Entity]
   861   C2350001:Parameter [Quantitative Concept]

Phrase: "was within normal variability."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0205307:Normal [Qualitative Concept]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0439166:% normal [Quantitative Concept]
   770   C1421478:WAS [Gene or Genome]
   770   C2347086:% Normal [Quantitative Concept]
   770   C2827666:Variability [Conceptual Entity]
Processing 00000000.tx.132: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.133: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.134: Plasma concentration of branched-chain amino acids (BCAA; sum of leucine, isoleucine, and valine) before, during, and after 1 bout of resistance exercise (Ex) during placebo or BCAA trial. 

Phrase: "Plasma concentration of branched-chain amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0683150:plasma concentration [Quantitative Concept]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "(BCAA"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "; sum of leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515051:Sum [Quantitative Concept]

Phrase: "isoleucine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022192:Isoleucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0523728:Isoleucine [Laboratory Procedure]

Phrase: "and"

Phrase: "valine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042285:Valine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "before,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "during,"

Phrase: "and after 1 bout of resistance exercise (Ex)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0015259:Exercise [Daily or Recreational Activity]
   748   C0237834:Resistance [Mental Process]
   748   C0741605:bout [Temporal Concept]
   748   C1514892:Resistance [Physiologic Function]
   748   C1515981:And [Idea or Concept]
   748   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "during placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "or"

Phrase: "BCAA trial."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0008976:Trial [Research Activity]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.135: Open symbols, BCAA trial; 

Phrase: "Open symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "BCAA trial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0008976:Trial [Research Activity]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.136: filled symbols, placebo trial. 

Phrase: "filled symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "placebo trial."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008976:Trial [Research Activity]
Processing 00000000.tx.137: Values are means  SE for 6 subjects. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE for 6 subjects."
Processing 00000000.tx.138: *P < 0.05 for BCAA vs. placebo.  

Phrase: "*P < 0.05 for BCAA"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   833   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0337112:Chain [Manufactured Object]
   744   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C1253959:branched [Body Part, Organ, or Organ Component]
   744   C1524075:Chain [Idea or Concept]
   744   C2603361:P' [Clinical Attribute]
   744   C2700384:Branched [Spatial Concept]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C1881507:Branch [Chemical Viewed Structurally]
   711 E C2700383:Branch [Plant]
   711 E C2826234:BRANCH [Intellectual Product]

Phrase: "vs. placebo."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]
Processing 00000000.tx.139: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.140: Plasma concentration of individual branched-chain amino acids  View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "Plasma concentration of individual branched-chain amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0683150:plasma concentration [Quantitative Concept]
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.141: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.142: Plasma concentration of insulin before, during, and after 1 bout of resistance exercise (Ex) during placebo or BCAA trial. 

Phrase: "Plasma concentration of insulin before,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0683150:plasma concentration [Quantitative Concept]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "during,"

Phrase: "and after 1 bout of resistance exercise"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0015259:Exercise [Daily or Recreational Activity]
   748   C0237834:Resistance [Mental Process]
   748   C0741605:bout [Temporal Concept]
   748   C1514892:Resistance [Physiologic Function]
   748   C1515981:And [Idea or Concept]
   748   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "(Ex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "during placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "or"

Phrase: "BCAA trial."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0008976:Trial [Research Activity]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.143: Open symbols, BCAA trial; 

Phrase: "Open symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "BCAA trial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0008976:Trial [Research Activity]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.144: filled symbols, placebo trial. 

Phrase: "filled symbols,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: "placebo trial."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008976:Trial [Research Activity]
Processing 00000000.tx.145: Values are means  SE for 6 subjects. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE for 6 subjects."
Processing 00000000.tx.146: *P < 0.05 for BCAA vs. placebo.  

Phrase: "*P < 0.05 for BCAA"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   833   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0337112:Chain [Manufactured Object]
   744   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C1253959:branched [Body Part, Organ, or Organ Component]
   744   C1524075:Chain [Idea or Concept]
   744   C2603361:P' [Clinical Attribute]
   744   C2700384:Branched [Spatial Concept]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C1881507:Branch [Chemical Viewed Structurally]
   711 E C2700383:Branch [Plant]
   711 E C2826234:BRANCH [Intellectual Product]

Phrase: "vs. placebo."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]
Processing 00000000.tx.147: Ser424/Thr421 phosphorylation of p70S6k in skeletal muscle was increased after exercise (Fig. 4; P < 0.05). 

Phrase: "Ser424/Thr421 phosphorylation of p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "was"

Phrase: "increased after exercise"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.148: Ser424/Thr421 phosphorylation of p70S6k, assessed immediately after exercise, was similar between placebo and BCAA trials. 

Phrase: "Ser424/Thr421 phosphorylation of p70S6k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "exercise,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "similar between placebo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "BCAA trials."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0008976:Trial [Research Activity]
Processing 00000000.tx.149: The exercise effect on Ser424/Thr421 phosphorylation of p70S6k persisted into the recovery phase. 

Phrase: "The exercise effect on Ser424/Thr421 phosphorylation of p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "persisted into the recovery phase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205390:Phase [Temporal Concept]
   760   C0237820:Recovery [Activity]
   760   C1555688:recovery [Idea or Concept]
   760   C2004454:Recovery [Organism Function]
Processing 00000000.tx.150: This persistent effect of exercise on p70S6k was further increased 3.5-fold (P < 0.05) during the BCAA trial. 

Phrase: "This persistent effect of exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "3.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0442758:3 5 [Quantitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "during the BCAA trial."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0008976:Trial [Research Activity]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.151: Thr389 phosphorylation of p70S6k was unaltered immediately after resistance exercise in both the placebo and BCAA trials (Fig. 5). 

Phrase: "Thr389 phosphorylation of p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "unaltered immediately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205548:Immediately [Temporal Concept]
   861   C1709843:Unaltered [Qualitative Concept]

Phrase: "after"

Phrase: "resistance exercise in both"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C0237834:Resistance [Mental Process]
   770   C1514892:Resistance [Physiologic Function]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "the placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "and"

Phrase: "BCAA trials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0008976:Trial [Research Activity]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.152: However, during recovery, Thr389 phosphorylation of p70S6k was increased, but only during the BCAA trial (Fig. 5, P < 0.05). 

Phrase: "However,"

Phrase: "during recovery,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "Thr389 phosphorylation of p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "but"

Phrase: "only during the BCAA trial"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   833   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0008976:Trial [Research Activity]
   744   C0205171:Only [Quantitative Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C1253959:branched [Body Part, Organ, or Organ Component]
   744   C1524075:Chain [Idea or Concept]
   744   C1720467:Only [Intellectual Product]
   744   C2700384:Branched [Spatial Concept]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C1881507:Branch [Chemical Viewed Structurally]
   711 E C2700383:Branch [Plant]
   711 E C2826234:BRANCH [Intellectual Product]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.153: This was further confirmed by a decrease in the electrophoretic mobility of p70S6k protein during recovery in the BCAA trial (Fig. 6). 

Phrase: "This"

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed by a decrease"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C0750484:Confirmed [Idea or Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "in the electrophoretic mobility"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0425245:Mobility [Finding]
   861   C0449580:Mobility [Qualitative Concept]
   789   C0013855:Electrophoreses [Laboratory Procedure]
   789 E C0231435:Mobile [Functional Concept]
   789 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "of p70S6k protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "during recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "in the BCAA trial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0008976:Trial [Research Activity]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.154: Importantly, phosphorylation of the ribosomal protein S6, a substrate of p70S6k, was markedly increased in the recovery period only during the BCAA trial (Fig. 7, P < 0.05). 

Phrase: "Importantly,"

Phrase: "phosphorylation of the ribosomal protein S6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "a substrate of p70S6k,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "increased in the recovery period only"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C2983655:Recovery Period [Temporal Concept]
   753   C0205171:Only [Quantitative Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0237820:Recovery [Activity]
   753   C0439531:/period [Temporal Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1555688:recovery [Idea or Concept]
   753   C1720467:Only [Intellectual Product]
   753   C1948053:Period [Temporal Concept]
   753   C2004454:Recovery [Organism Function]

Phrase: "during the BCAA trial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0008976:Trial [Research Activity]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.155: View larger version (19K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.156: 4. 

Phrase: "4."
Processing 00000000.tx.157: 70-kDa S6 protein kinase (p70S6k) phosphorylation at Ser424/Thr421 in skeletal muscle at rest and after exercise during placebo and BCAA trials. 

Phrase: "70-kDa S6 protein kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: ")"

Phrase: "phosphorylation at Ser424/Thr421"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "and after exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "during placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "and"

Phrase: "BCAA trials."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0008976:Trial [Research Activity]
Processing 00000000.tx.158: Representative immunoblots are shown (top). 

Phrase: "Representative immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(top)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.159: Values in graph are arbitrary units (means  SE for 7 subjects). 

Phrase: "Values in graph"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "(means  SE for 7 subjects"

Phrase: ")."
Processing 00000000.tx.160: #P < 0.05 vs. rest; 

Phrase: "#P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: ";"
Processing 00000000.tx.161: *P < 0.05 for BCAA vs. placebo.  

Phrase: "*P < 0.05 for BCAA"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   833   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0337112:Chain [Manufactured Object]
   744   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C1253959:branched [Body Part, Organ, or Organ Component]
   744   C1524075:Chain [Idea or Concept]
   744   C2603361:P' [Clinical Attribute]
   744   C2700384:Branched [Spatial Concept]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C1881507:Branch [Chemical Viewed Structurally]
   711 E C2700383:Branch [Plant]
   711 E C2826234:BRANCH [Intellectual Product]

Phrase: "vs. placebo."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]
Processing 00000000.tx.162: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.164: p70S6k phosphorylation at Thr389 in skeletal muscle at rest and after exercise during placebo and BCAA trials. 

Phrase: "p70S6k phosphorylation at Thr389"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "and after exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "during placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "and"

Phrase: "BCAA trials."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0008976:Trial [Research Activity]
Processing 00000000.tx.165: Representative immunoblots are shown (top). 

Phrase: "Representative immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(top)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.166: Values in graph are arbitrary units (means  SE for 7 subjects). 

Phrase: "Values in graph"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "(means  SE for 7 subjects"

Phrase: ")."
Processing 00000000.tx.167: #P < 0.05 vs. rest; 

Phrase: "#P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: ";"
Processing 00000000.tx.168: *P < 0.05 for BCAA vs. placebo.  

Phrase: "*P < 0.05 for BCAA"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   833   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0337112:Chain [Manufactured Object]
   744   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C1253959:branched [Body Part, Organ, or Organ Component]
   744   C1524075:Chain [Idea or Concept]
   744   C2603361:P' [Clinical Attribute]
   744   C2700384:Branched [Spatial Concept]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C1881507:Branch [Chemical Viewed Structurally]
   711 E C2700383:Branch [Plant]
   711 E C2826234:BRANCH [Intellectual Product]

Phrase: "vs. placebo."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]
Processing 00000000.tx.169: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.170: 6. 

Phrase: "6."
Processing 00000000.tx.171: p70S6k phosphorylation as determined by 6% SDS-PAGE mobility shift assay. 

Phrase: "p70S6k phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "as"

Phrase: "determined by 6% SDS-PAGE mobility shift assay."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0949632:Mobility Shift Assay [Laboratory Procedure]
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C0333051:Shift [Functional Concept]
   744   C0425245:Mobility [Finding]
   744   C0449580:Mobility [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1704732:Page [Intellectual Product]
   744   C2347509:Shift [Phenomenon or Process]
Processing 00000000.tx.172: Muscle biopsies were obtained before and after exercise and during recovery in placebo and BCAA trials. 

Phrase: "Muscle biopsies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0185283:Muscle biopsy [Diagnostic Procedure]
   861   C0005558:biopsies [Diagnostic Procedure]
   827 E C0220797:biopsy [Functional Concept]

Phrase: "were"

Phrase: "obtained before"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   833   C1301820:Obtained [Functional Concept]
   799 E C1706701:Obtain [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "and after exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "and during recovery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0237820:Recovery [Activity]
   790   C1515981:And [Idea or Concept]
   790   C1555688:recovery [Idea or Concept]
   790   C2004454:Recovery [Organism Function]

Phrase: "in placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "and"

Phrase: "BCAA trials."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0008976:Trial [Research Activity]
Processing 00000000.tx.173: Representative immunoblots (A and B) are shown for 2 subjects.  

Phrase: "Representative immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "are"

Phrase: "shown for 2 subjects."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   737   C0681850:Subject [Group]
   737   C1547282:Show [Intellectual Product]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.174: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.175: 7. 

Phrase: "7."
Processing 00000000.tx.176: Phosphorylation of the ribosomal protein S6 in skeletal muscle at rest and after exercise during placebo and BCAA trials. 

Phrase: "Phosphorylation of the ribosomal protein S6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "and after exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "during placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "and"

Phrase: "BCAA trials."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0008976:Trial [Research Activity]
Processing 00000000.tx.177: Representative immunoblots are shown (top). 

Phrase: "Representative immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(top)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.178: Values in graphs are arbitrary units (means  SE for 7 subjects). 

Phrase: "Values in graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "(means  SE for 7 subjects"

Phrase: ")."
Processing 00000000.tx.179: #P < 0.05 vs. rest; 

Phrase: "#P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: ";"
Processing 00000000.tx.180: *P < 0.05 for BCAA vs. placebo.  

Phrase: "*P < 0.05 for BCAA"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   833   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0337112:Chain [Manufactured Object]
   744   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C1253959:branched [Body Part, Organ, or Organ Component]
   744   C1524075:Chain [Idea or Concept]
   744   C2603361:P' [Clinical Attribute]
   744   C2700384:Branched [Spatial Concept]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]
   711 E C1881507:Branch [Chemical Viewed Structurally]
   711 E C2700383:Branch [Plant]
   711 E C2826234:BRANCH [Intellectual Product]

Phrase: "vs. placebo."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]
Processing 00000000.tx.181: Resistance exercise led to a marked increase in phosphorylation of ERK1/2 MAPK (Fig. 8; P < 0.05) and p38 MAPK (Fig. 9; P < 0.05) immediately after exercise. 

Phrase: "Resistance exercise"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "led to a marked increase"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0442805:Increase [Functional Concept]
   760   C0522501:Marked [Qualitative Concept]
   760   C1706089:Marked [Qualitative Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of ERK1/2 MAPK"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   895   C0082529:ERK1 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0026249:Mitogen [Pharmacologic Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1879547:Activated [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "p38 MAPK"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "; P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.182: One hour after exercise, ERK1/2 and p38 MAPK phosphorylation was similar to preexercise levels. 

Phrase: "One hour after exercise,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439227:Hour [Temporal Concept]
   770   C0564385:/hour [Quantitative Concept]

Phrase: "ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p38 MAPK phosphorylation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   839   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "similar to preexercise levels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.183: In contrast to p70S6k, phosphorylation of ERK1/2 and p38 MAPK was unaltered by BCAA. 

Phrase: "In contrast to p70S6k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "phosphorylation of ERK1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "p38 MAPK"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "was"

Phrase: "unaltered by BCAA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1709843:Unaltered [Qualitative Concept]
   716   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.184: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.185: 8. 

Phrase: "8."
Processing 00000000.tx.186: ERK1/2 phosphorylation at Thr202/Tyr204 in skeletal muscle at rest and after exercise during placebo and BCAA trials. 

Phrase: "ERK1/2 phosphorylation at Thr202/Tyr204"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "and after exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "during placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "and"

Phrase: "BCAA trials."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0008976:Trial [Research Activity]
Processing 00000000.tx.187: Representative immunoblots are shown (top). 

Phrase: "Representative immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(top)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.188: Values in graphs are arbitrary units (means  SE for 7 subjects). 

Phrase: "Values in graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "(means  SE for 7 subjects"

Phrase: ")."
Processing 00000000.tx.189: #P < 0.05 vs. rest.  

Phrase: "#P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. rest."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]
Processing 00000000.tx.190: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.191: 9. 

Phrase: "9."
Processing 00000000.tx.192: p38 MAPK phosphorylation at Thr180/Tyr182 in muscle biopsies in skeletal muscle at rest and after exercise during placebo and BCAA trials. 

Phrase: "p38 MAPK phosphorylation at Thr180/Tyr182"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]

Phrase: "in muscle biopsies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0185283:Muscle biopsy [Diagnostic Procedure]
   861   C0005558:biopsies [Diagnostic Procedure]
   827 E C0220797:biopsy [Functional Concept]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "at rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "and after exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1515981:And [Idea or Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "during placebo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032042:placebo [Therapeutic or Preventive Procedure]
  1000   C1696465:placebo [Biomedical or Dental Material]
  1000   C1706408:PLACEBO [Research Activity]

Phrase: "and"

Phrase: "BCAA trials."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C0008976:Trial [Research Activity]
Processing 00000000.tx.193: Representative immunoblots are shown (top). 

Phrase: "Representative immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(top)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.194: Values in graph are arbitrary units (means  SE for 7 subjects). 

Phrase: "Values in graph"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0042295:Values [Qualitative Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   966   C0439183:Arbitrary unit [Quantitative Concept]
   861   C0439148:Units [Quantitative Concept]
   861   C1264693:*Arbitrary [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "(means  SE for 7 subjects"

Phrase: ")."
Processing 00000000.tx.195: #P < 0.05 vs. rest.  

Phrase: "#P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. rest."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]
Processing 00000000.tx.196: DISCUSSION The major finding of the present study is that branched-chain amino acid ingestion during and after acute resistance exercise increases site-specific phosphorylation and activation of p70S6k in skeletal muscle. 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "The major finding of the present study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037088:Finding [Sign or Symptom]
   748   C0243095:Finding [Finding]
   748   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "that branched-chain amino acid ingestion during"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0237965:ACID INGESTION [Injury or Poisoning]
   748   C0232478:Ingestion [Biologic Function]

Phrase: "and after acute resistance exercise"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0015259:Exercise [Daily or Recreational Activity]
   760   C0205178:acute [Temporal Concept]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
   760   C1515981:And [Idea or Concept]
   760   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "site-specific phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   734   C0449604:site specific [Spatial Concept]

Phrase: "and"

Phrase: "activation of p70S6k"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "in skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.197: This is evident by our findings of increased site-specific phosphorylation at Ser424/Thr421 and Thr389, decreased electrophoretic mobility of p70S6k protein, and increased phosphorylation of the ribosomal protein S6, a substrate of p70S6k in skeletal muscle, during recovery from exercise in the BCAA trial. 

Phrase: "This"

Phrase: "is"

Phrase: "evident by our findings of increased site-specific phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332120:Evidence of [Functional Concept]

Phrase: "at Ser424/Thr421"

Phrase: "and"

Phrase: "Thr389,"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "electrophoretic mobility of p70S6k protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0201719:Protein electrophoresis [Laboratory Procedure]
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "and"

Phrase: "increased phosphorylation of the ribosomal protein S6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   748   C0031715:Phosphorylation [Molecular Function]

Phrase: "a substrate of p70S6k"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]

Phrase: "in skeletal muscle,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "during recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "from exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "in the BCAA trial."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0008976:Trial [Research Activity]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.198: Resistance exercise was also associated with increased phosphorylation of ERK1/2 and p38 MAPK. 

Phrase: "Resistance exercise"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "was"

Phrase: "also"

Phrase: "associated with increased phosphorylation of ERK1/2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1158886:Phosphorylation [Molecular Function]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "p38 MAPK."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.199: However, in contrast to p70S6k, exercise effects on MAPK were transient, and levels returned to basal within 1 h after exercise. 

Phrase: "However,"

Phrase: "in contrast to p70S6k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "exercise effects on MAPK"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "transient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040704:Transient [Population Group]
  1000   C0205374:Transient [Temporal Concept]

Phrase: "and"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "returned to basal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   866   C0332156:Return to [Qualitative Concept]
           Return
   790   C0205112:Basal [Spatial Concept]

Phrase: "within 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "after exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.200: Furthermore, BCAA were without effect on MAPK, providing evidence that changes in p70S6k phosphorylation are a specific, rather than a generalized, effect of BCAA. 

Phrase: "Furthermore,"

Phrase: "BCAA"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "were without effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on MAPK,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that changes in p70S6k phosphorylation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "a specific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "rather than"

Phrase: "a generalized, effect of BCAA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.201: p70S6k is activated by phosphorylation at several Ser/Thr residues. 

Phrase: "p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "is"

Phrase: "activated by phosphorylation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "at several Ser/Thr residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.202: Phosphorylation of four residues (Ser411, Ser418, Thr421, and Ser424) in the COOH-terminal autoinhibitory domain is required for altering the conformation of p70S6k and making Thr389 and Ser404 in the linker domain and Thr229 in the catalytic domain available for phosphorylation, thereby activating p70S6k (6, 23). 

Phrase: "Phosphorylation of four residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Ser411,"

Phrase: "Ser418,"

Phrase: "Thr421,"

Phrase: "and"

Phrase: "Ser424"

Phrase: ")"

Phrase: "in the COOH-terminal autoinhibitory domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "required for altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Required [Functional Concept]

Phrase: "the conformation of p70S6k"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026377:Conformation [Spatial Concept]

Phrase: "and"

Phrase: "making Thr389"

Phrase: "and"

Phrase: "Ser404 in the linker domain"

Phrase: "and"

Phrase: "Thr229 in the catalytic domain"

Phrase: "available for phosphorylation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "thereby"

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "(6,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.203: One session of resistance exercise was not sufficient to fully phosphorylate and activate p70S6k. 

Phrase: "One session of resistance exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883016:Session [Event]
   760   C1883017:Session [Conceptual Entity]

Phrase: "was"

Phrase: "not sufficient to fully"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205410:Sufficient [Qualitative Concept]
   812   C1518422:Not [Functional Concept]

Phrase: "phosphorylate"

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "p70S6k."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]
Processing 00000000.tx.204: However, exercise in combination with BCAA ingestion led to a striking effect on p70S6k, as evident by site-specific phosphorylation at Thr389. 

Phrase: "However,"

Phrase: "exercise in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "with BCAA ingestion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   823   C0237965:ACID INGESTION [Injury or Poisoning]
   804   C0232478:Ingestion [Biologic Function]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "led to a striking effect"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0038452:striking [Occupational Activity]
   760   C1280500:Effect [Qualitative Concept]
   760   C1708698:LED [Manufactured Object]
   760   C2348382:Effect [Qualitative Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "on p70S6k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "as"

Phrase: "evident by site-specific phosphorylation"

Phrase: "at Thr389."
Processing 00000000.tx.205: Phosphorylation of this residue is key for the activity of p70S6k (6, 23). 

Phrase: "Phosphorylation of this residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "key for the activity of p70S6k"

Phrase: "(6,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.206: Moreover, phosphorylation of the ribosomal protein S6 was increased in skeletal muscle, indicating that p70S6k was activated. 

Phrase: "Moreover,"

Phrase: "phosphorylation of the ribosomal protein S6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "increased in skeletal muscle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0242692:Muscle, Skeletal [Tissue]
   833   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   770   C0026845:Muscle [Tissue]
   770   C0037253:skeletal [Body System]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0521324:Skeletal [Spatial Concept]

Phrase: "indicating"

Phrase: "that p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "was"

Phrase: "activated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.207: Repeated isometric contractions for 30 min (induced by stimulation of the sciatic nerve in rats) increase phosphorylation of p70S6k at Thr389 in gastrocnemius muscle, with persistent effects noted 2 and 6 h after contraction (10). 

Phrase: "Repeated isometric contractions for 30 min ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022205:Isometric Contractions [Organ or Tissue Function]
   753   C1140999:contractions [Pathologic Function]

Phrase: "induced by stimulation of the sciatic nerve"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0036394:Sciatic Nerve [Body Part, Organ, or Organ Component]
   778   C1278851:Sciatic nerve [Body Part, Organ, or Organ Component]
   748   C0027740:Nerve [Tissue]
   748   C0027757:NERVE [Tissue]
   748   C0205263:Induced [Functional Concept]
   748   C1280541:Nerve [Body Part, Organ, or Organ Component]
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: ")"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "phosphorylation of p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "at Thr389"

Phrase: "in gastrocnemius muscle,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0242691:Gastrocnemius Muscle [Body Part, Organ, or Organ Component]
           Gastrocnemius
   861   C0026845:Muscle [Tissue]
   861   C1305344:Gastrocnemius [Body Part, Organ, or Organ Component]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "with persistent effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "6 h after contraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1140999:Contraction [Pathologic Function]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.208: Furthermore, a skeletal muscle fiber type-specific effect of sciatic nerve stimulation (60 contractions of 3 s over a 20-min period) has been reported on p70S6k activity, as noted by a decrease in the electrophoretic mobility of p70S6k protein, with largest effects in fast-twitch (extensor digitorum longus and tibialis anterior) muscles and no effect noted in slow-twitch (soleus) muscle (1a, 18). 

Phrase: "Furthermore,"

Phrase: "a skeletal muscle fiber type-specific effect of sciatic nerve stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]

Phrase: "(60 contractions of 3 s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1140999:contractions [Pathologic Function]

Phrase: "over a 20-min period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "reported on p70S6k activity,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1561536:*Activity [Idea or Concept]
   770   C2827383:p70S6K [Enzyme]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "as"

Phrase: "noted by a decrease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "in the electrophoretic mobility"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0425245:Mobility [Finding]
   861   C0449580:Mobility [Qualitative Concept]
   789   C0013855:Electrophoreses [Laboratory Procedure]
   789 E C0231435:Mobile [Functional Concept]
   789 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "of p70S6k protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with largest effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "in fast-twitch"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015663:Fast [Finding]
   861   C0231530:Twitch [Sign or Symptom]
   861   C0456962:Fast [Qualitative Concept]

Phrase: "(extensor digitorum longus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0224464:Extensor digitorum longus [Body Part, Organ, or Organ Component]
  1000   C1305067:Extensor digitorum longus [Body Part, Organ, or Organ Component]
   901   C0224268:Extensor digitorum [Body Part, Organ, or Organ Component]
   901   C1304999:Extensor digitorum [Body Part, Organ, or Organ Component]
   827   C1184148:Extensor [Body Location or Region]

Phrase: "and"

Phrase: "tibialis anterior) muscles"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   966   C0242690:Tibialis anterior muscle [Body Part, Organ, or Organ Component]
           Tibialis anterior
   901   C1305065:Tibialis anterior [Body Part, Organ, or Organ Component]
   896   C1710422:Tibialis Muscle [Body Part, Organ, or Organ Component]
           Tibialis
   827   C0026845:Muscles [Tissue]
   827   C0205094:Anterior [Spatial Concept]
   827   C1995013:Muscles [Body Part, Organ, or Organ Component]
   743 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "noted in slow-twitch"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0231530:Twitch [Sign or Symptom]
   770   C0439834:Slow [Qualitative Concept]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "(soleus) muscle"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0242694:Soleus Muscle [Body Part, Organ, or Organ Component]
           Soleus
   861   C0026845:Muscle [Tissue]
   861   C1305356:Soleus [Body Part, Organ, or Organ Component]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "(1a,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.209: However, this apparent tissue-specific effect is likely to be related to the mode of contraction (concentric vs. eccentric) and intensity of the exercise, rather than to a fiber type difference, because a prolonged increase in p70S6k activity was observed only after eccentric exercise (18). 

Phrase: "However,"

Phrase: "this apparent tissue-specific effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1280500:Effect [Qualitative Concept]
   812   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "related to the mode of contraction"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C1140999:Contraction [Pathologic Function]
   753   C1513371:Mode [Functional Concept]
   753   C1705738:Mode [Quantitative Concept]
   753   C2347637:Mode [Quantitative Concept]
   753   C2348146:Mode [Quantitative Concept]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "(concentric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439744:Concentric [Spatial Concept]

Phrase: "vs. eccentric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439740:Eccentric [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "intensity of the exercise,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "rather than to a fiber type difference,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0000696:A Fiber [Tissue]
   748   C0012173:Fiber [Food]
   748   C0225326:Fiber [Pharmacologic Substance]
   748   C0304068:Fiber [Plant]
   748   C0332307:Type [Qualitative Concept]
   748   C1260603:Fiber [Plant]
   748   C1304649:Fiber [Tissue]
   748   C1547052:*Type [Quantitative Concept]
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "because"

Phrase: "a prolonged increase in p70S6k activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only after eccentric exercise"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C0205171:Only [Quantitative Concept]
   770   C0439740:Eccentric [Qualitative Concept]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]
   770   C1720467:Only [Intellectual Product]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.210: Our results provide evidence that acute resistance exercise increases p70S6k phosphorylation in human skeletal muscle composed of a mixture of fibers with different contractile and metabolic characteristics (7, 8). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that acute resistance exercise"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0015259:Exercise [Daily or Recreational Activity]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1522704:Exercise [Therapeutic or Preventive Procedure]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "p70S6k phosphorylation in human skeletal muscle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "composed of a mixture of fibers"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   753   C0439962:Mixture [Substance]
   753   C1304649:Fibers [Tissue]
   719 E C0012173:Fiber [Food]
   719 E C0225326:Fiber [Pharmacologic Substance]
   719 E C0304068:Fiber [Plant]
   719 E C1260603:Fiber [Plant]

Phrase: "with different contractile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026820:Contractile [Physiologic Function]

Phrase: "and"

Phrase: "metabolic characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.211: However, the exercise effect on p70S6k was limited to Ser424/Thr421, because phosphorylation of Thr389 and S6 was unaltered, indicating that the kinase was incompletely activated. 

Phrase: "However,"

Phrase: "the exercise effect on p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "limited to Ser424/Thr421,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439801:Limited [Functional Concept]
   770   C3542948:Limited [Intellectual Product]
   737 E C1549649:Limit [Idea or Concept]
   737 E C2349209:Limit [Conceptual Entity]

Phrase: "because"

Phrase: "phosphorylation of Thr389"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "S6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1419024:S6 [Gene or Genome]
  1000   C1419741:S6 [Gene or Genome]
  1000   C1861424:S6 [Gene or Genome]
  1000   C2348600:S6+ [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "unaltered,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709843:Unaltered [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "incompletely"

Phrase: "activated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.212: This finding is in contrast to studies in rodents (1a, 10, 18), whereby p70S6k activity is increased in skeletal muscle in response to either isometric or eccentric contractions achieved by electrical nerve stimulation. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is in contrast to studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0947630:studies [Laboratory Procedure]
   760   C1979874:Contrast [Qualitative Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "in rodents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodents [Mammal]

Phrase: "(1a,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "10,"

Phrase: "18"

Phrase: ")"

Phrase: ","

Phrase: "whereby p70S6k activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "increased in skeletal muscle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0242692:Muscle, Skeletal [Tissue]
   833   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   770   C0026845:Muscle [Tissue]
   770   C0037253:skeletal [Body System]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0521324:Skeletal [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to either isometric"

Phrase: "or"

Phrase: "eccentric contractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1140999:contractions [Pathologic Function]

Phrase: "achieved by electrical nerve stimulation."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   797   C0013786:Electrical Stimulation [Therapeutic or Preventive Procedure]
   760   C0013790:Electrical [Natural Phenomenon or Process]
   760   C0027740:Nerve [Tissue]
   760   C0027757:NERVE [Tissue]
   760   C0442828:Electrical [Functional Concept]
   760   C1280541:Nerve [Body Part, Organ, or Organ Component]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
   704 E C0599851:Neural [Functional Concept]
Processing 00000000.tx.213: Thus a contraction-specific effect, rather than a fiber type-specific effect, may be responsible for the exercise-induced increase in p70S6k activity. 

Phrase: "Thus"

Phrase: "a contraction-specific effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "rather than"

Phrase: "a fiber type-specific effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1280500:Effect [Qualitative Concept]
   804   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "responsible for the exercise-induced increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "in p70S6k activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.214: However, because the exercise regimen employed in the present study involved eccentric and concentric movements, other factors including exercise intensity or nutritional status may account for differences between responses in humans (present study) and rodents (1a, 10, 18). 

Phrase: "However,"

Phrase: "because"

Phrase: "the exercise regimen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040808:Regimen [Therapeutic or Preventive Procedure]
   861   C2945654:regimen [Intellectual Product]

Phrase: "employed in the present study"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557351:Employed [Finding]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726 E C0457083:Employ [Functional Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "eccentric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439740:Eccentric [Qualitative Concept]

Phrase: "and"

Phrase: "concentric movements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026649:Movement [Organism Function]

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "exercise intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "or"

Phrase: "nutritional status"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0392209:Nutritional status [Organism Attribute]
   861   C0449438:Status [Qualitative Concept]
   861   C1521739:Nutritional [Qualitative Concept]
   861   C2707262:Nutritional [Clinical Attribute]

Phrase: "may"

Phrase: "account for differences"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1551359:account [Idea or Concept]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "between responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0871261:responses [Organism Attribute]
   966 E C1704632:Response [Finding]
   966 E C1706817:Response [Intellectual Product]
   966 E C2911692:Response [Mental Process]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "(present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "rodents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodents [Mammal]

Phrase: "(1a,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "10,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.215: Future studies to explore whether exercise effects on p70S6k activity in human skeletal muscle are dependent on mode of contraction (eccentric or concentric), exercise intensity, nutritional status, or skeletal muscle fiber type composition per se are warranted. 

Phrase: "Future"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016884:Future [Temporal Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "whether"

Phrase: "exercise effects on p70S6k activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "in human skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]

Phrase: "are"

Phrase: "dependent on mode of contraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "(eccentric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439740:Eccentric [Qualitative Concept]

Phrase: "or"

Phrase: "concentric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439744:Concentric [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "exercise intensity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "nutritional status,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0392209:Nutritional status [Organism Attribute]
   861   C0449438:Status [Qualitative Concept]
   861   C1521739:Nutritional [Qualitative Concept]
   861   C2707262:Nutritional [Clinical Attribute]

Phrase: "or"

Phrase: "skeletal muscle fiber type composition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0486616:Composition [Clinical Attribute]
   804   C1555710:composition [Idea or Concept]
   717   C1704336:Skeletal muscle fiber [Cell]

Phrase: "per se"

Phrase: "are"

Phrase: "warranted."
Processing 00000000.tx.216: Ingestion of BCAA markedly enhanced site-specific phosphorylation of p70S6k at Ser421/Thr424 and Thr389 in human skeletal muscle 1 and 2 h after resistance exercise. 

Phrase: "Ingestion of BCAA markedly enhanced site-specific phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0232478:Ingestion [Biologic Function]
   737   C0237965:ACID INGESTION [Injury or Poisoning]

Phrase: "of p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "at Ser421/Thr424"

Phrase: "and"

Phrase: "Thr389 in human skeletal muscle 1"

Phrase: "and"

Phrase: "2 h after resistance exercise."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0011744:2 H [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.217: Infusion of leucine for 2 h is associated with increased p70S6k phosphorylation in skeletal muscle from human subjects at rest (9). 

Phrase: "Infusion of leucine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0574032:Infusion [Therapeutic or Preventive Procedure]
   790   C1827465:Infusion [Functional Concept]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "is"

Phrase: "associated with increased p70S6k phosphorylation"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C2827383:p70S6K [Enzyme]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "from human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "subjects at rest"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C0681850:Subject [Group]
   790   C1550501:{Subject} [Idea or Concept]
   790   C1622890:ResT [Molecular Function]
   790   C1706203:Subject [Idea or Concept]
   790   C2349001:Subject [Human]
   790   C2697811:Subject [Functional Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.218: Coinfusion of leucine and insulin led to a further increase in p70S6k phosphorylation, providing evidence that leucine and insulin may increase p70S6k activity through different pathways (9). 

Phrase: "Coinfusion of leucine"

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "led to a further increase"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   760   C0442805:Increase [Functional Concept]
   760   C1517331:Further [Spatial Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C0205108:far [Spatial Concept]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in p70S6k phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "p70S6k activity through different pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.219: In a recent study (2), a combination of insulin and amino acids was required to stimulate protein synthesis and inhibit protein degradation. 

Phrase: "In a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "a combination of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "protein degradation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0597297:Protein Degradation [Molecular Function]
  1000   C0597304:Protein Degradation [Molecular Function]
  1000   C1623036:Protein Degradation [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.220: In the present study, plasma insulin concentration was increased during exercise, which is in agreement with a recent study (25). 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "plasma insulin concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0683150:plasma concentration [Quantitative Concept]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0857690:plasma insulin [Laboratory Procedure]

Phrase: "was"

Phrase: "increased during exercise,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "which"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.221: However, this is not a universal finding, since in some studies insulin is not altered by resistance exercise in the fasting state (3, 15). 

Phrase: "However,"

Phrase: "this"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a universal finding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "since in some"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1711239:Since [Temporal Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by resistance exercise"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C0237834:Resistance [Mental Process]
   770   C0392747:Altered [Functional Concept]
   770   C1514892:Resistance [Physiologic Function]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "in the fasting state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015663:Fasting state [Finding]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.222: In any case, the increase in insulin levels observed in this study was mild, and at the time when p70S6k phosphorylation was greatest, insulin levels were not higher than preexercise levels. 

Phrase: "In any case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the increase in insulin levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0020459:INSULIN INCREASE [Disease or Syndrome]
   760   C0442805:Increase [Functional Concept]

Phrase: "observed in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1441672:Observed [Functional Concept]
   770   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "mild,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945599:Mild [Qualitative Concept]

Phrase: "and at the time"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0040223:Time [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "when"

Phrase: "p70S6k phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "greatest, insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "not higher than preexercise levels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.223: Intake of BCAA did not alter p70S6k phosphorylation in skeletal muscle directly after exercise; 

Phrase: "Intake of BCAA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0556117:Branched chain amino acid intake [Finding]
   804   C0556114:Amino acid intake [Finding]
   753   C1512806:Intake [Functional Concept]
   716   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "p70S6k phosphorylation in skeletal muscle directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "after"

Phrase: "exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.224: rather, the effects were noted in the hours postexercise. 

Phrase: "rather,"

Phrase: "the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "noted in the hours postexercise."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0439227:hours [Temporal Concept]
   760   C1979962:post exercise [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.225: This finding may possibly reflect the latent effect of amino acids on protein synthesis. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "may"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the latent effect of amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on protein synthesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.226: In a recent study (5) in which a mixture of amino acids was infused to human subjects at rest, skeletal muscle protein synthesis was not altered during the first 30 min of amino acid infusion, but then rose rapidly between 30 and 60 min of infusion, and remained elevated for another hour of amino acid infusion. 

Phrase: "In a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "in which"

Phrase: "a mixture of amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "infused to human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Human [Human]

Phrase: "subjects at rest,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0035253:Rest [Daily or Recreational Activity]
   790   C0681850:Subject [Group]
   790   C1550501:{Subject} [Idea or Concept]
   790   C1622890:ResT [Molecular Function]
   790   C1706203:Subject [Idea or Concept]
   790   C2349001:Subject [Human]
   790   C2697811:Subject [Functional Concept]

Phrase: "skeletal muscle protein synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0597295:Protein Synthesis [Molecular Function]
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered during the first 30 min of amino acid infusion,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   782   C1273690:Amino acid infusion [Pharmacologic Substance]
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0456693:/30 min [Temporal Concept]
   760   C1442458:30 min [Temporal Concept]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0205435:First [Quantitative Concept]
   739   C0392747:Altered [Functional Concept]
   739   C0574032:Infusion [Therapeutic or Preventive Procedure]
   739   C0702093:/min [Temporal Concept]
   739   C1279901:First [Qualitative Concept]
   739   C1827465:Infusion [Functional Concept]

Phrase: "but"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "rapidly between 30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1637379:Rapidly [Qualitative Concept]

Phrase: "and"

Phrase: "60 min of infusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "remained"

Phrase: "elevated for another hour of amino acid infusion."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C1273690:Amino acid infusion [Pharmacologic Substance]
   770   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C2917660:Amino Acid [Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0205250:Elevated [Qualitative Concept]
   744   C0439227:Hour [Temporal Concept]
   744   C0564385:/hour [Quantitative Concept]
   744   C0574032:Infusion [Therapeutic or Preventive Procedure]
   744   C1827465:Infusion [Functional Concept]
   744   C3163633:Elevated [Qualitative Concept]
Processing 00000000.tx.227: A link between the MAPK-signaling pathway and translation initiation of protein synthesis has been suggested via MAPK-integrating kinase-1 (24). 

Phrase: "A link between the MAPK-signaling pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0065011:link protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1517892:Link [Intellectual Product]
   739   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "translation initiation of protein synthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C1157563:protein synthesis initiation [Genetic Function]
   844   C1448475:Translation Initiation, Protein [Genetic Function]
   806   C1519613:Translation Initiation [Genetic Function]
   760   C0589507:Initiation [Mental Process]
   760   C1158830:Initiation [Genetic Function]
   760   C1704686:Initiation [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "suggested via MAPK-integrating kinase-1"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   860   C0173879:Mitogen-Activated Protein Kinase Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   860   C1334474:MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 [Gene or Genome]
   860   C1434639:Mitogen-Activated Protein Kinase Kinase-1 [Amino Acid, Peptide, or Protein,Enzyme]
   838   C0170168:Mitogen Activated Protein Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   838   C1366882:MITOGEN-ACTIVATED PROTEIN KINASE 1 [Gene or Genome]
   818   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   796   C0169101:Mitogen-Activated Protein Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   764   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0026249:Mitogen [Pharmacologic Substance]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1879547:Activated [Activity]
   708 E C1515877:Activate [Functional Concept]
   708   C1705535:Suggest [Idea or Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.228: Resistance exercise was associated with increased ERK1/2 and p38 MAPK phosphorylation immediately after exercise. 

Phrase: "Resistance exercise"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "was"

Phrase: "associated with increased ERK1/2"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "p38 MAPK phosphorylation immediately"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   829   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   747   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   710   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "after"

Phrase: "exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.229: In a previous report, one session of knee extensor resistance exercise in young male subjects was associated with an increase in ERK1/2 MAPK phosphorylation, with no effect on p38 MAPK phosphorylation (27). 

Phrase: "In a previous report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "one session of knee extensor resistance exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1883016:Session [Event]
   748   C1883017:Session [Conceptual Entity]

Phrase: "in young male subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "was"

Phrase: "associated with an increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0442805:Increase [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in ERK1/2 MAPK phosphorylation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   829   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   710   C0082529:ERK1 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   710   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on p38 MAPK phosphorylation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   839   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.230: However, here we report that resistance training is associated with increased phosphorylation of ERK1/2 and p38 MAPK. 

Phrase: "However,"

Phrase: "here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that resistance training"
Meta Candidates (Total=16; Excluded=9; Pruned=0; Remaining=7)
  1000   C0814409:resistance training [Health Care Activity]
  1000   C0872279:Resistance Training [Therapeutic or Preventive Procedure]
   861   C0040607:Training [Educational Activity]
   861   C0220931:Training [Educational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C2673163:training [Qualitative Concept]
   827 E C0336809:Train [Manufactured Object]
   827 E C1552514:Train [Manufactured Object]
   789 E C0009647:Conditioned [Mental Process]
   789 E C0012634:condition [Disease or Syndrome]
   789 E C0332325:Resistant [Functional Concept]
   789 E C0348080:Condition [Qualitative Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C1705253:Condition [Conceptual Entity]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "is"

Phrase: "associated with increased phosphorylation of ERK1/2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1158886:Phosphorylation [Molecular Function]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "p38 MAPK."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.231: The reason for the divergent results between these studies may be explained by the different exercise regimens. 

Phrase: "The reason for the divergent results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392360:Reason [Idea or Concept]

Phrase: "between these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "be"

Phrase: "explained by the different exercise regimens."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0015259:Exercise [Daily or Recreational Activity]
   753   C1522704:Exercise [Therapeutic or Preventive Procedure]
   753   C1705242:Different [Qualitative Concept]
   753   C2945654:regimens [Intellectual Product]
   719 E C0040808:Regimen [Therapeutic or Preventive Procedure]
Processing 00000000.tx.232: Eccentric contractions during the leg press exercise employed in the present study may have been more pronounced than those elicited during knee extensor exercise in the previous report (27). 

Phrase: "Eccentric contractions during the leg press exercise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1140999:contractions [Pathologic Function]

Phrase: "employed in the present study"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557351:Employed [Finding]
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]
   726 E C0457083:Employ [Functional Concept]

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced than those"

Phrase: "elicited during knee extensor exercise"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C0454364:exercise knee [Therapeutic or Preventive Procedure]
   760   C0015259:Exercise [Daily or Recreational Activity]
   760   C0022742:Knee [Body Part, Organ, or Organ Component]
   760   C0022745:Knee [Body Space or Junction]
   760   C0449265:elicited [Qualitative Concept]
   760   C1184148:Extensor [Body Location or Region]
   760   C1283838:Knee [Body Location or Region]
   760   C1522704:Exercise [Therapeutic or Preventive Procedure]
   760   C1963703:Knee [Body Location or Region]

Phrase: "in the previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.233: Consistent with this hypothesis, in isolated rat skeletal muscle, concentric contractions have been reported to increase ERK1/2 MAPK phosphorylation, with no effect on p38 MAPK, whereas eccentric contractions increase phosphorylation along both kinase cascades (28). 

Phrase: "Consistent with this hypothesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in isolated rat skeletal muscle,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   861   C0242692:Muscle, Skeletal [Tissue]
   861   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   812   C0026845:Muscle [Tissue]
   812   C0037253:skeletal [Body System]
   812   C0521324:Skeletal [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "concentric contractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1140999:contractions [Pathologic Function]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "ERK1/2 MAPK phosphorylation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   829   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   795   C0031715:Phosphorylation [Molecular Function]
   710   C0082529:ERK1 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   710   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on p38 MAPK,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "whereas"

Phrase: "eccentric contractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1140999:contractions [Pathologic Function]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "phosphorylation along both kinase cascades"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.234: Alternatively, the divergent effects on MAPK signaling may be related to the training status of the subjects, because exercise-induced signaling responses may be greater in trained subjects (30). 

Phrase: "Alternatively,"

Phrase: "the divergent effects on MAPK signaling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "related to the training status of the subjects,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   744   C0040607:Training [Educational Activity]
   744   C0220931:Training [Educational Activity]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0449438:Status [Qualitative Concept]
   744   C2673163:training [Qualitative Concept]
   735   C3176928:Condition status [Clinical Attribute]
   711 E C0163712:Relate [Organic Chemical]
   711 E C0336809:Train [Manufactured Object]
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711 E C1552514:Train [Manufactured Object]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]

Phrase: "because"

Phrase: "exercise-induced signaling responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]

Phrase: "may"

Phrase: "be"

Phrase: "greater in trained subjects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.235: The effect of resistance exercise on MAPK signaling is transient. 

Phrase: "The effect of resistance exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on MAPK signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "transient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040704:Transient [Population Group]
  1000   C0205374:Transient [Temporal Concept]
Processing 00000000.tx.236: Activation of ERK 1/2 and p38 MAPK returned to resting levels 1 h after resistance exercise, a finding consistent with previous work from our laboratory (26). 

Phrase: "Activation of ERK 1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1879547:Activation [Activity]
   703   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   703   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]

Phrase: "and"

Phrase: "p38 MAPK"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "returned to resting levels 1 h"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   783   C0700308:h 1 [Element, Ion, or Isotope]
   773   C0332156:Return to [Qualitative Concept]
           Return
   773   C0456947:Level 1 [Intellectual Product]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0035253:Resting [Daily or Recreational Activity]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441889:Levels [Qualitative Concept]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1512899:resting [Cell]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C1622890:ResT [Molecular Function]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "after resistance exercise,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "consistent with previous work"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "from our laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.237: However, the lack of an effect of BCAA on MAPK responses after exercise provides evidence that effects on p70S6k are not generalized, but rather specific effects. 

Phrase: "However,"

Phrase: "the lack of an effect of BCAA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0332268:lack [Qualitative Concept]

Phrase: "on MAPK responses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0871261:responses [Organism Attribute]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   771 E C1704632:Response [Finding]
   771 E C1706817:Response [Intellectual Product]
   771 E C2911692:Response [Mental Process]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: "after exercise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that effects on p70S6k"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "generalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205246:Generalized [Spatial Concept]

Phrase: ","

Phrase: "but"

Phrase: "rather specific effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.238: In summary, resistance exercise increased Ser424/Thr421 phosphorylation of p70S6k in skeletal muscle. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "resistance exercise increased Ser424/Thr421 phosphorylation of p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "in skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.239: This effect was sustained 2 h after exercise. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "sustained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443318:Sustained [Functional Concept]
   966 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "2 h after exercise."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0011744:2 H [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.240: Resistance exercise was without effect on phosphorylation of p70S6k on Thr389 and S6 in skeletal muscle. 

Phrase: "Resistance exercise"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "was without effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1280500:Effect [Qualitative Concept]
   790   C1421478:WAS [Gene or Genome]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "on Thr389"

Phrase: "and"

Phrase: "S6 in skeletal muscle."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1419024:S6 [Gene or Genome]
   770   C1419741:S6 [Gene or Genome]
   770   C1861424:S6 [Gene or Genome]
   770   C2348600:S6+ [Element, Ion, or Isotope]
Processing 00000000.tx.241: ERK1/2 and p38 MAPK phosphorylation was also increased after resistance exercise. 

Phrase: "ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p38 MAPK phosphorylation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   839   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "also"

Phrase: "increased after resistance exercise."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0015259:Exercise [Daily or Recreational Activity]
   770   C0205217:Increased [Quantitative Concept]
   770   C0237834:Resistance [Mental Process]
   770   C0442805:Increased [Functional Concept]
   770   C1514892:Resistance [Physiologic Function]
   770   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.242: However, this effect was transient, because ERK1/2 and p38 MAPK phosphorylation was indistinguishable from basal levels 1 h after exercise. 

Phrase: "However,"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "transient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040704:Transient [Population Group]
  1000   C0205374:Transient [Temporal Concept]

Phrase: "because"

Phrase: "ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p38 MAPK phosphorylation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   839   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   799   C0031715:Phosphorylation [Molecular Function]
   780   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "indistinguishable from basal levels 1 h"

Phrase: "after exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.243: Ingestion of BCAA during and after resistance exercise further increased phosphorylation of p70S6k protein at Ser424/Thr421. 

Phrase: "Ingestion of BCAA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0237965:ACID INGESTION [Injury or Poisoning]
   753   C0232478:Ingestion [Biologic Function]
   716   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "during"

Phrase: "and after resistance exercise further increased phosphorylation of p70S6k protein"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   739   C0015259:Exercise [Daily or Recreational Activity]
   739   C0031715:Phosphorylation [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205217:Increased [Quantitative Concept]
   739   C0237834:Resistance [Mental Process]
   739   C0442805:Increased [Functional Concept]
   739   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1514892:Resistance [Physiologic Function]
   739   C1515981:And [Idea or Concept]
   739   C1517331:Further [Spatial Concept]
   739   C1522704:Exercise [Therapeutic or Preventive Procedure]
   739   C2827383:p70S6K [Enzyme]
   706 E C0205108:far [Spatial Concept]

Phrase: "at Ser424/Thr421."
Processing 00000000.tx.244: Moreover, BCAA ingestion increased phosphorylation of p70S6k protein at Thr389, decreased electrophoretic mobility of p70S6k protein, and increased S6 phosphorylation in skeletal muscle. 

Phrase: "Moreover,"

Phrase: "BCAA ingestion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   823   C0237965:ACID INGESTION [Injury or Poisoning]
   804   C0232478:Ingestion [Biologic Function]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "phosphorylation of p70S6k protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   770   C0031715:Phosphorylation [Molecular Function]

Phrase: "at Thr389,"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "electrophoretic mobility of p70S6k protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0201719:Protein electrophoresis [Laboratory Procedure]
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "and"

Phrase: "increased S6 phosphorylation in skeletal muscle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.245: In contrast to results for p70S6k, BCAA ingestion was without effect on ERK 1/2 and p38 MAPK. 

Phrase: "In contrast to results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "for p70S6k,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136240:p70s6k [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2827383:p70S6K [Enzyme]

Phrase: "BCAA ingestion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   823   C0237965:ACID INGESTION [Injury or Poisoning]
   804   C0232478:Ingestion [Biologic Function]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was without effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1280500:Effect [Qualitative Concept]
   790   C1421478:WAS [Gene or Genome]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on ERK 1/2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   947   C0082529:Extracellular Signal-Regulated Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   947   C1366765:EXTRACELLULAR SIGNAL-REGULATED KINASE 1 [Gene or Genome]
   941   C0170168:Extracellular Signal-Regulated Kinase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   941   C1366882:EXTRACELLULAR SIGNAL-REGULATED KINASE 2 [Gene or Genome]
   880   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   880   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0521119:Extracellular [Cell Component]
   799   C0851285:Regulated [Governmental or Regulatory Activity]
   799   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "p38 MAPK."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.246: Thus we speculate that BCAA may enhance protein synthesis in skeletal muscle during recovery from resistance exercise training through a p70S6k-dependent (MAPK-independent) signaling cascade. 

Phrase: "Thus"

Phrase: "we"

Phrase: "speculate"

Phrase: "that BCAA"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "may"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "protein synthesis in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0597295:Protein Synthesis [Molecular Function]
   797   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "during recovery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237820:Recovery [Activity]
  1000   C1555688:recovery [Idea or Concept]
  1000   C2004454:Recovery [Organism Function]

Phrase: "from resistance exercise training"
Meta Candidates (Total=18; Excluded=9; Pruned=0; Remaining=9)
   913   C0814409:resistance training [Health Care Activity]
   913   C0872279:Resistance Training [Therapeutic or Preventive Procedure]
   827   C0015259:Exercise [Daily or Recreational Activity]
   827   C0040607:Training [Educational Activity]
   827   C0220931:Training [Educational Activity]
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   827   C1522704:Exercise [Therapeutic or Preventive Procedure]
   827   C2673163:training [Qualitative Concept]
   793 E C0336809:Train [Manufactured Object]
   793 E C1552514:Train [Manufactured Object]
   755 E C0009647:Conditioned [Mental Process]
   755 E C0012634:condition [Disease or Syndrome]
   755 E C0332325:Resistant [Functional Concept]
   755 E C0348080:Condition [Qualitative Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C1705253:Condition [Conceptual Entity]
   755 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "through a p70S6k-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "(MAPK-independent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0085862:Independent [Idea or Concept]
   804   C1299583:Independent [Finding]
   771   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "signaling cascade."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2611812:signaling cascade [Cell Function]
   861   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.247: GRANTS The study was supported by grants from the Swedish National Centre for Research in Sports (to E. Blomstrand and J. R. Zierath) and from the Swedish Medical Research Council, the Swedish Diabetes Association, the Foundation for Scientific Studies of Diabetology, and Novo-Nordisk (to J. R. Zierath).  

Phrase: "GRANTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018173:Grants [Quantitative Concept]
   966 E C1548284:Grant [Idea or Concept]

Phrase: "The study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Swedish National Centre"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "for Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "in Sports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "("

Phrase: "to E. Blomstrand"

Phrase: "and"

Phrase: "J. R. Zierath"

Phrase: ")"

Phrase: "and from the Swedish Medical Research Council,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0079816:Medical Research [Research Activity]
   778   C1556038:Medical Research [Professional or Occupational Group]
   748   C0035168:research [Research Activity]
   748   C0205476:Medical [Functional Concept]
   748   C0242481:Research [Research Activity]
   748   C1515981:And [Idea or Concept]
   748   C1551807:Council [Population Group]
   748   C1710263:Swedish [Population Group]

Phrase: "the Swedish Diabetes Association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "the Foundation for Scientific Studies of Diabetology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0016617:Foundation [Organization]

Phrase: "and"

Phrase: "Novo-Nordisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331875:Novo Nordisk [Health Care Related Organization]

Phrase: "("

Phrase: "to J. R. Zierath"

Phrase: ")."
Processing 00000000.tx.248: FOOTNOTES  Address for reprint requests and other correspondence: E. 

Phrase: "FOOTNOTES  Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "E."
Processing 00000000.tx.249: Blomstrand, Univ. 

Phrase: "Blomstrand,"

Phrase: "Univ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041740:UNIV [Manufactured Object,Organization]
Processing 00000000.tx.250: College of Physical Education and Sports, Box 5626, S-114 86 Stockholm, Sweden (E-mail: eva.blomstrand{at}ihs.se ). 

Phrase: "College of Physical Education"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0870309:college education [Educational Activity]
   770   C0557806:College [Manufactured Object]

Phrase: "and"

Phrase: "Sports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "Box 5626,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "S-"

Phrase: "114 86 Stockholm,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "eva.blomstrand{at}ihs.se"

Phrase: ")."
Processing 00000000.tx.251: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.252: The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.253: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.254: FOOTNOTES * H. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "* H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.255: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.256: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.257: Karlsson and P. 

Phrase: "Karlsson"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.258: A. 

Phrase: "A."
Processing 00000000.tx.259: Nilsson contributed equally to this article. 

Phrase: "Nilsson"

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this article."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1706852:Article [Intellectual Product]
Processing 00000000.tx.260: REFERENCES strand PO and Rodahl K. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]

Phrase: "strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "PO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442027:PO [Spatial Concept]

Phrase: "and"

Phrase: "Rodahl K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.261: Textbook of Work Physiology. 

Phrase: "Textbook of Work Physiology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0039712:textbook [Intellectual Product,Manufactured Object]
Processing 00000000.tx.262: New York: McGraw-Hill, 1986. 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "McGraw-Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: "1986."
Processing 00000000.tx.263: Baar K and Esser K. 

Phrase: "Baar K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Esser K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.264: Phosphorylation of p70S6k correlates with increased skeletal muscle mass following resistance exercise. 

Phrase: "Phosphorylation of p70S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "correlates with increased skeletal muscle mass"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0240417:MUSCLE MASS [Finding]
   790   C0242692:Muscle, Skeletal [Tissue]
   790   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   753   C0026845:Muscle [Tissue]
   753   C0037253:skeletal [Body System]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0521324:Skeletal [Spatial Concept]
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C3152252:Mass [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "resistance exercise."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.265: Am J Physiol Cell Physiol 276: C120C127, 1999.[Abstract/Free FullText] Balage M, Sinaud S, Prod'Homme M, Dardevet D, Vary TC, Kimball SR, Jefferson LS, and Grizard J. 

Phrase: "Am"

Phrase: "J Physiol Cell Physiol 276"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "C120C127,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Balage M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sinaud S,"

Phrase: "Prod'Homme M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Dardevet D,"

Phrase: "Vary"

Phrase: "TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041405:TC [Geographic Area]
  1000   C1824670:TC [Gene or Genome]
  1000   C3272447:TC [Gene or Genome]

Phrase: "Kimball SR,"

Phrase: "Jefferson LS,"

Phrase: "and"

Phrase: "Grizard J."
Processing 00000000.tx.266: Amino acids and insulin are both required to regulate assembly of the eIF4EeIF4G complex in rat skeletal muscle. 

Phrase: "Amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "both"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "assembly of the eIF4EeIF4G complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]

Phrase: "in rat skeletal muscle."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.267: Am J Physiol Endocrinol Metab 281: E565E574, 2001.[Abstract/Free FullText] Biolo G, Williams B, Fleming R, and Wolfe R. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 281"

Phrase: ":"

Phrase: "E565E574,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Biolo G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Williams B,"

Phrase: "Fleming R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wolfe R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.268: Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise. 

Phrase: "Insulin action on muscle protein kinetics"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0920875:Muscle action [Organ or Tissue Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0441472:Action [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3266814:Action [Activity]

Phrase: "and"

Phrase: "amino acid transport during recovery"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0596078:amino acid transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "after resistance exercise."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.269: Diabetes 48: 949957, 1999.[Abstract] Blomstrand E and Saltin B. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "949957,"

Phrase: "1999."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Blomstrand E"

Phrase: "and"

Phrase: "Saltin B."
Processing 00000000.tx.270: BCAA intake affects protein metabolism in muscle after but not during exercise in humans. 

Phrase: "BCAA intake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0556117:Branched chain amino acid intake [Finding]
   867   C0556114:Amino acid intake [Finding]
   804   C1512806:Intake [Functional Concept]
   771   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "protein metabolism in muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0597299:Protein Metabolism [Molecular Function]
   819   C0596984:metabolism muscle [Organ or Tissue Function]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]

Phrase: "after"

Phrase: "but"

Phrase: "not during exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0015259:Exercise [Daily or Recreational Activity]
   790   C1518422:Not [Functional Concept]
   790   C1522704:Exercise [Therapeutic or Preventive Procedure]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.271: Am J Physiol Endocrinol Metab 281: E365E374, 2001.[Abstract/Free FullText] Boh J, Low JFA, Wolfe RR, and Rennie MJ. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 281"

Phrase: ":"

Phrase: "E365E374,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Boh J,"

Phrase: "Low JFA,"

Phrase: "Wolfe RR,"

Phrase: "and"

Phrase: "Rennie MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.272: Latency and duration of stimulation of human muscle protein synthesis during continuous infusion of amino acids. 

Phrase: "Latency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205275:Latent [Qualitative Concept]

Phrase: "and"

Phrase: "duration of stimulation of human muscle protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449238:Duration [Temporal Concept]
   744   C2926735:Duration [Pharmacologic Substance]

Phrase: "during continuous infusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444889:Continuous infusion [Therapeutic or Preventive Procedure]
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "of amino acids."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.273: J Physiol 532: 575579, 2001.[Abstract/Free FullText] Dufner A and Thomas G. 

Phrase: "J Physiol 532"

Phrase: ":"

Phrase: "575579,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Dufner"

Phrase: "A"

Phrase: "and"

Phrase: "Thomas G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.274: Ribosomal S6 kinase signaling and the control of translation. 

Phrase: "Ribosomal S6 kinase signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037083:Signaling [Cell Function]
   812   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "the control of translation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.275: Exp Cell Res 253: 100109, 1999.[CrossRef][ISI][Medline] Essn B, Jansson E, Henriksson J, Taylor AW, and Saltin B. 

Phrase: "Exp Cell Res 253"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1417055:EXP [Gene or Genome]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "100109,"

Phrase: "1999."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Essn B,"

Phrase: "Jansson E,"

Phrase: "Henriksson J,"

Phrase: "Taylor AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "and"

Phrase: "Saltin B."
Processing 00000000.tx.276: Metabolic characteristics of fibre types in human skeletal muscle. 

Phrase: "Metabolic characteristics of fibre types"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C3645613:Characteristic type [Intellectual Product]
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "in human skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.277: Acta Physiol Scand 95: 153165, 1975.[ISI][Medline] Garnett RA, O'Donovan MJ, Stephens JA, and Taylor A. 

Phrase: "Acta Physiol Scand 95"

Phrase: ":"

Phrase: "153165,"

Phrase: "1975."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Garnett RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "O'Donovan MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439254:MJ [Medical Device]

Phrase: "Stephens JA,"

Phrase: "and"

Phrase: "Taylor A."
Processing 00000000.tx.278: Motor unit organization of human medial gastrocnemius. 

Phrase: "Motor unit organization of human medial gastrocnemius."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   774   C1547792:Organization Unit [Organization]
   748   C0029237:Organisation [Physiologic Function]
   748   C0029246:Organization [Organization]
       E   Organizational Unit
   748   C0220885:organization [Qualitative Concept]
   748   C1300196:Organization [Functional Concept]
   748   C1522486:Organization [Professional or Occupational Group]
Processing 00000000.tx.279: J Physiol 287: 3343, 1979.[ISI][Medline] Greiwe JS, Kwon G, McDaniel ML, and Semenkovich CF. 

Phrase: "J Physiol 287"

Phrase: ":"

Phrase: "3343,"

Phrase: "1979."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Greiwe JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Kwon G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "McDaniel ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "Semenkovich CF."
Processing 00000000.tx.280: Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. 

Phrase: "Leucine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "p70 S6 kinase through different pathways"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1136240:p70 S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in human skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.281: Am J Physiol Endocrinol Metab 281: E466E471, 2001.[Abstract/Free FullText] Haddad F and Adams GR. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 281"

Phrase: ":"

Phrase: "E466E471,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Haddad F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Adams GR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]
Processing 00000000.tx.282: Selected contribution: acute cellular and molecular responses to resistance exercise. 

Phrase: "Selected contribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880177:Contribution [Activity]

Phrase: ":"

Phrase: "acute cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0007634:Cellular [Cell]
   861   C0178539:Cellular [Functional Concept]
   789 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular responses to resistance exercise."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C2265833:response to exercise [Organism Function]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]
Processing 00000000.tx.283: J Appl Physiol 93: 394403, 2002.[Abstract/Free FullText] Henriksson KG. 

Phrase: "J Appl Physiol 93"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "394403,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Henriksson KG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]
Processing 00000000.tx.284: "Semi-open" muscle biopsy technique. 

Phrase: """Semi-"

Phrase: "open"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]

Phrase: """ muscle biopsy technique."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0449851:Technique [Functional Concept]
   743 E C0025664:techniques [Intellectual Product]
   734   C0185283:Muscle biopsy [Diagnostic Procedure]
Processing 00000000.tx.285: A simple outpatient procedure. 

Phrase: "A simple outpatient procedure."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1299353:Outpatient procedure [Therapeutic or Preventive Procedure]
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.286: Acta Neurol Scand 59: 317323, 1979.[ISI][Medline] Hernandez JM, Fedele MJ, and Farrell PA. 

Phrase: "Acta Neurol Scand 59"

Phrase: ":"

Phrase: "317323,"

Phrase: "1979."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hernandez JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Fedele MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "and"

Phrase: "Farrell PA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]
Processing 00000000.tx.287: Time course evaluation of protein synthesis and glucose uptake after acute resistance exercise in rats. 

Phrase: "Time course evaluation of protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "glucose uptake after acute resistance exercise"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1159527:glucose uptake [Cell Function]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.288: J Appl Physiol 88: 11421149, 2000.[Abstract/Free FullText] Kimball SR, Farrell PA, and Jefferson LS. 

Phrase: "J Appl Physiol 88"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "11421149,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimball SR,"

Phrase: "Farrell PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "and"

Phrase: "Jefferson LS."
Processing 00000000.tx.289: Invited Review: Role of insulin in translational control of protein synthesis in skeletal muscle by amino acids or exercise. 

Phrase: "Invited"

Phrase: "Review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: ":"

Phrase: "Role of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "in translational control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0243148:control [Qualitative Concept]
   861   C1519614:Translational [Genetic Function]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   789 E C0040712:Translation [Intellectual Product]
   789 E C0597295:translation [Molecular Function]

Phrase: "of protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "in skeletal muscle"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "by amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.290: J Appl Physiol 93: 11681180, 2002.[Abstract/Free FullText] Kleijn M, Scheper GC, Voorma HO, and Thomas AA. 

Phrase: "J Appl Physiol 93"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "11681180,"

Phrase: "2002."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kleijn M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Scheper GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Voorma HO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832110:HO [Gene or Genome]

Phrase: "and"

Phrase: "Thomas AA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]
Processing 00000000.tx.291: Regulation of translation initiation factors by signal transduction. 

Phrase: "Regulation of translation initiation factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   908   C1157543:regulation of translational initiation [Cell Function]
   862   C1157519:regulation of translation [Cell Function]
   762   C3537096:Translational Regulation [Genetic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by signal transduction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037083:Signal Transduction [Cell Function]
   861   C1160185:transduction [Organism Function]
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.292: Eur J Biochem 253: 531544, 1998.[Abstract] Kraemer WJ, Volek JS, Bush JA, Putukian M, and Sebastianelli WJ. 

Phrase: "Eur J Biochem 253"

Phrase: ":"

Phrase: "531544,"

Phrase: "1998."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kraemer WJ,"

Phrase: "Volek JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Bush JA,"

Phrase: "Putukian M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Sebastianelli WJ."
Processing 00000000.tx.293: Hormonal responses to consecutive days of heavy-resistance exercise with or without nutritional supplementation. 

Phrase: "Hormonal responses to consecutive days of heavy-resistance exercise"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   773   C2265833:response to exercise [Organism Function]
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "with"

Phrase: "or without nutritional supplementation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242295:Nutritional supplementation [Food]
   833   C0242297:nutritional supplementation [Therapeutic or Preventive Procedure]
           Supplementation
   770   C1521739:Nutritional [Qualitative Concept]
   770   C2707262:Nutritional [Clinical Attribute]
Processing 00000000.tx.294: J Appl Physiol 85: 15441555, 1998.[Abstract/Free FullText] Liu Z, Jahn LA, Long W, Fryburg DA, Wei L, and Barrett EJ. 

Phrase: "J Appl Physiol 85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "15441555,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu Z,"

Phrase: "Jahn LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Long W,"

Phrase: "Fryburg DA,"

Phrase: "Wei L,"

Phrase: "and"

Phrase: "Barrett EJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]
Processing 00000000.tx.295: Branched chain amino acids activate messenger ribonucleic acid translation regulatory proteins in human skeletal muscle, and glucocorticoids blunt this action. 

Phrase: "Branched chain amino acids"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0002521:Amino Acids, Branched-Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   812   C0337112:Chain [Manufactured Object]
   812   C1253959:branched [Body Part, Organ, or Organ Component]
   812   C1524075:Chain [Idea or Concept]
   812   C2700384:Branched [Spatial Concept]
   779 E C0202406:Acid [Laboratory Procedure]
   779 E C1881507:Branch [Chemical Viewed Structurally]
   779 E C2700383:Branch [Plant]
   779 E C2826234:BRANCH [Intellectual Product]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "messenger ribonucleic acid translation regulatory proteins in human skeletal muscle,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0815047:regulatory proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0026832:Muscle Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1142652:human proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0169911:messenger protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   741   C0597295:Protein Translation [Molecular Function]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0220905:regulatory [Regulation or Law]
   739   C1704735:Regulatory [Conceptual Entity]

Phrase: "and"

Phrase: "glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "blunt"

Phrase: "this action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]
Processing 00000000.tx.296: J Clin Endocrinol Metab 86: 21362143, 2001.[Abstract/Free FullText] Louard RJ, Barrett EJ, and Gelfand RA. 

Phrase: "J Clin Endocrinol Metab 86"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "21362143,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Louard RJ,"

Phrase: "Barrett EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "and"

Phrase: "Gelfand RA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]
Processing 00000000.tx.297: Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man. 

Phrase: "Effect of infused branched-chain amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "whole-body amino acid metabolism in man."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0596076:amino acid metabolism [Molecular Function]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.298: Clin Sci (Lond) 79: 457466, 1990.[ISI][Medline] Nader GA and Esser KA. 

Phrase: "Clin Sci (Lond) 79"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1315013:CLIN [Intellectual Product]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "457466,"

Phrase: "1990."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nader GA"

Phrase: "and"

Phrase: "Esser KA."
Processing 00000000.tx.299: Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. 

Phrase: "Intracellular signaling specificity in skeletal muscle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to different modes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1513371:Mode [Functional Concept]
   827   C1705738:Mode [Quantitative Concept]
   827   C2347637:Mode [Quantitative Concept]
   827   C2348146:Mode [Quantitative Concept]

Phrase: "of exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015259:Exercise [Daily or Recreational Activity]
  1000   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.300: J Appl Physiol 90: 19361942, 2001.[Abstract/Free FullText] Nair KS, Schwartz RG, and Welle S. 

Phrase: "J Appl Physiol 90"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "19361942,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nair KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Schwartz RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "and"

Phrase: "Welle S."
Processing 00000000.tx.301: Leucine as a regulator of whole body and skeletal muscle protein metabolism in humans. 

Phrase: "Leucine as a regulator of whole body"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "skeletal muscle protein metabolism in humans."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0597299:Protein Metabolism [Molecular Function]
   783   C0596984:metabolism muscle [Organ or Tissue Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.302: Am J Physiol Endocrinol Metab 263: E928E934, 1992. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 263"

Phrase: ":"

Phrase: "E928E934,"

Phrase: "1992."
Processing 00000000.tx.303: Pearson RB and Thomas G. 

Phrase: "Pearson RB"

Phrase: "and"

Phrase: "Thomas G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.304: Regulation of p70S6k/p85S6k and its role in the cell cycle. 

Phrase: "Regulation of p70S6k/p85S6k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "its role in the cell cycle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.305: Prog Cell Cycle Res 1: 2132, 1995.[Medline] Pfeifer R, Korpi J, Burgoyne R, and McCourt D. 

Phrase: "Prog Cell Cycle Res 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0007586:Cell Cycle [Cell Function]
   840   C1155839:Cell Cycle [Cell Function]
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1511572:Cycle [Temporal Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "2132,"

Phrase: "1995."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pfeifer R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Korpi J,"

Phrase: "Burgoyne R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "McCourt D."
Processing 00000000.tx.306: Practical application of HPLC to amino acid analyses. 

Phrase: "Practical application of HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0185125:Application [Health Care Activity]
   770   C1947919:Application [Intellectual Product]
   770   C2347934:Application [Intellectual Product]
   770   C3539080:APPLICATION [Quantitative Concept]

Phrase: "to amino acid analyses."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
Processing 00000000.tx.307: Am Lab 15: 7784, 1983. 

Phrase: "Am"

Phrase: "Lab 15"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0022877:Lab [Manufactured Object,Organization]
   805 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   777 E C0587081:Labs [Finding]

Phrase: ":"

Phrase: "7784,"

Phrase: "1983."
Processing 00000000.tx.308: Phillips SM, Tipton KD, Aarsland A, Wolf SE, and Wolfe RR. 

Phrase: "Phillips SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Tipton KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Aarsland A,"

Phrase: "Wolf SE,"

Phrase: "and"

Phrase: "Wolfe RR."
Processing 00000000.tx.309: Mixed muscle protein synthesis and breakdown after resistance exercise in humans. 

Phrase: "Mixed muscle protein synthesis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0026832:Muscle Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597295:Protein Synthesis [Molecular Function]
   812   C0026845:Muscle [Tissue]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]
   741 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "breakdown after resistance exercise"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443161:break down [Qualitative Concept]
   770   C0699900:breakdown [Organism Function]
   770   C1265875:breakdown [Acquired Abnormality]

Phrase: "in humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]
Processing 00000000.tx.310: Am J Physiol Endocrinol Metab 273: E99E107, 1997.[Abstract/Free FullText] Pullen N and Thomas G. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 273"

Phrase: ":"

Phrase: "E99E107,"

Phrase: "1997."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pullen N"

Phrase: "and"

Phrase: "Thomas G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.311: The modular phosphorylation and activation of p70s6k. 

Phrase: "The modular phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "activation of p70s6k."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]
Processing 00000000.tx.312: FEBS Lett 410: 7882, 1997.[CrossRef][ISI][Medline] Raught B and Gingras AC. 

Phrase: "FEBS Lett 410"

Phrase: ":"

Phrase: "7882,"

Phrase: "1997."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Raught B"

Phrase: "and"

Phrase: "Gingras AC."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]
Processing 00000000.tx.313: eIF4E activity is regulated at multiple levels. 

Phrase: "eIF4E activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "regulated at multiple levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0439064:Multiple [Quantitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.314: Int J Biochem Cell Biol 31: 4357, 1999.[CrossRef][ISI][Medline] Tipton KD, Rasmussen BB, Miller SL, Wolf SE, Owens-Stovall SK, Petrini BE, and Wolfe RR. 

Phrase: "Int J Biochem Cell Biol 31"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   799   C0007634:Cell [Cell]
   799   C0063789:INT [Organic Chemical]
   799   C0450355:31 [Intellectual Product]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "4357,"

Phrase: "1999."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tipton KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Rasmussen BB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: "Miller SL,"

Phrase: "Wolf SE,"

Phrase: "Owens-Stovall SK,"

Phrase: "Petrini"

Phrase: "BE"

Phrase: ","

Phrase: "and"

Phrase: "Wolfe RR."
Processing 00000000.tx.315: Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise. 

Phrase: "Timing of amino acid-carbohydrate ingestion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449243:Timing [Temporal Concept]
   753   C1704250:Timing [Conceptual Entity]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "anabolic response of muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "to resistance exercise."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0015259:Exercise [Daily or Recreational Activity]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1522704:Exercise [Therapeutic or Preventive Procedure]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.316: Am J Physiol Endocrinol Metab 281: E197E206, 2001.[Abstract/Free FullText] Widegren U, Jiang XJ, Krook A, Chibalin AV, Bjornholm M, Tally M, Roth RA, Henriksson J, Wallberg-Henriksson H, and Zierath JR. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 281"

Phrase: ":"

Phrase: "E197E206,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Widegren U,"

Phrase: "Jiang XJ,"

Phrase: "Krook A,"

Phrase: "Chibalin AV,"

Phrase: "Bjornholm M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tally M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roth RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Henriksson J,"

Phrase: "Wallberg-Henriksson H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Zierath JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.317: Divergent effects of exercise on metabolic and mitogenic signaling pathways in human skeletal muscle. 

Phrase: "Divergent effects of exercise"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311400:Metabolic [Functional Concept]
  1000   C1524026:Metabolic [Cell Function]
  1000   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "mitogenic signaling pathways in human skeletal muscle."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   774   C0037080:pathways signaling [Molecular Function]
   762 E C0037083:signaling pathway [Cell Function]
   762 E C0086982:Signaling Pathway [Molecular Function]
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.318: FASEB J 12: 13791389, 1998.[Abstract/Free FullText] Williamson D, Gallagher P, Harber M, Hollon C, and Trappe S. 

Phrase: "FASEB J 12"

Phrase: ":"

Phrase: "13791389,"

Phrase: "1998."

Phrase: "[Abstract/Free FullText"

Phrase: "] Williamson D,"

Phrase: "Gallagher P,"

Phrase: "Harber M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hollon C,"

Phrase: "and"

Phrase: "Trappe S."
Processing 00000000.tx.319: Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle. 

Phrase: "Mitogen-activated protein kinase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "(MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: ")"

Phrase: "pathway activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: ":"

Phrase: "effects of age"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "acute exercise on human skeletal muscle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015259:Exercise [Daily or Recreational Activity]
   753   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.320: J Physiol 547: 977987, 2003.[Abstract/Free FullText] Wretman C, Lionikas A, Widegren U, Lannergren J, Westerblad H, and Henriksson J. 

Phrase: "J Physiol 547"

Phrase: ":"

Phrase: "977987,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wretman C,"

Phrase: "Lionikas A,"

Phrase: "Widegren U,"

Phrase: "Lannergren J,"

Phrase: "Westerblad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Henriksson J."
Processing 00000000.tx.321: Effects of concentric and eccentric contractions on phosphorylation of MAPK(ERK1/2) and MAPK(p38) in isolated rat skeletal muscle. 

Phrase: "Effects of concentric"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "eccentric contractions on phosphorylation of MAPK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1140999:contractions [Pathologic Function]

Phrase: "(ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "and"

Phrase: "MAPK"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "(p38"

Phrase: ")"

Phrase: "in isolated rat skeletal muscle."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C1882854:Rat Skeletal Muscle [Body Part, Organ, or Organ Component]
   861   C0242692:Muscle, Skeletal [Tissue]
   861   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   812   C0026845:Muscle [Tissue]
   812   C0037253:skeletal [Body System]
   812   C0521324:Skeletal [Spatial Concept]
   741 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.322: J Physiol 535: 155164, 2001.[Abstract/Free FullText] Yu M, Blomstrand E, Chibalin AV, Krook A, and Zierath JR. 

Phrase: "J Physiol 535"

Phrase: ":"

Phrase: "155164,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Blomstrand E,"

Phrase: "Chibalin AV,"

Phrase: "Krook A,"

Phrase: "and"

Phrase: "Zierath JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.323: Marathon running increases ERK1/2 and p38 MAP kinase signalling to downstream targets in human skeletal muscle. 

Phrase: "Marathon running"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035953:Running [Daily or Recreational Activity]
   861   C2346414:Running [Finding]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "ERK1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082529:ERK-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "p38 MAP kinase signalling to downstream targets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C3537152:signalling [Biologic Function]
   714 E C1710082:Signal [Phenomenon or Process]

Phrase: "in human skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0242692:Muscle, Skeletal [Tissue]
   901   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0037253:skeletal [Body System]
   827   C0521324:Skeletal [Spatial Concept]
   755 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.324: J Physiol 536: 273282, 2001.[Abstract/Free FullText] Yu M, Stepto NK, Chibalin AV, Fryer LGD, Carling D, Krook A, Hawley JA, and Zierath JR. 

Phrase: "J Physiol 536"

Phrase: ":"

Phrase: "273282,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stepto NK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]

Phrase: "Chibalin AV,"

Phrase: "Fryer LGD,"

Phrase: "Carling D,"

Phrase: "Krook A,"

Phrase: "Hawley JA,"

Phrase: "and"

Phrase: "Zierath JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.325: Metabolic and mitogenic signal transduction in human skeletal muscle after intense cycling exercise. 

Phrase: "Metabolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311400:Metabolic [Functional Concept]
  1000   C1524026:Metabolic [Cell Function]
  1000   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "mitogenic signal transduction in human skeletal muscle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0037083:Signal Transduction [Cell Function]
   748   C1160185:transduction [Organism Function]
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "after intense cycling exercise."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015259:Exercise [Daily or Recreational Activity]
   827   C1522704:Exercise [Therapeutic or Preventive Procedure]
Processing 00000000.tx.326: J Physiol 546: 327335, 2003.[Abstract/Free FullText]

Phrase: "J Physiol 546"

Phrase: ":"

Phrase: "327335,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

